
  
    
      
        Background_NNP
        Estrogenic_NNP steroids_NNS regulate_VB cellular_JJ function_NN in_IN a_DT wide_JJ
        variety_NN of_IN tissues_NNS [_NN 1_CD ]_NN ._. During_IN human_JJ pregnancy_NN ,_, the_DT
        production_NN of_IN 17_CD -_: beta-estradiol_JJ (_( E_NNP 2_LS )_) rises_VBZ eighty_NN fold_VB ,_,
        from_IN 0_CD ._. 75_CD nM_NN preovulatory_NN peak_NN to_TO 60_CD nM_NN at_IN term_NN [_NN 2_CD 3_CD 4_CD 5_CD ]_NN
        ,_, and_CC estrogens_NNS influence_VBP various_JJ aspects_NNS of_IN placental_NN
        function_NN and_CC fetal_JJ development_NN in_IN humans_NNS and_CC primates_NNS [_NN 6_CD 7_CD
        8_CD 9_CD 10_CD 11_CD 12_CD ]_NN ._. Several_JJ previous_JJ studies_NNS have_VBP shown_VBN that_IN
        human_JJ placenta_NN binds_NNS estradiol_NN [_NN 13_CD 14_CD 15_CD ]_NN ._. However_RB ,_, more_RBR
        recent_JJ immunohistochemical_JJ studies_NNS on_IN paraffin-embedded_JJ or_CC
        snap_NN frozen_VBN sections_NNS as_RB well_RB as_IN other_JJ techniques_NNS (_( RT-PCR_NNP
        for_IN ER-alpha_NNP mRNA_NN )_) failed_VBD to_TO demonstrate_VB estrogen_NN receptor_NN
        alpha_NN (_( ERα_NNP )_) in_IN human_JJ placentae_NN during_IN pregnancy_NN or_CC in_IN
        cultures_NNS of_IN dispersed_VBD placental_NN cells_NNS [_NN 16_CD 17_CD ]_NN ._. However_RB ,_,
        it_PRP has_VBZ been_VBN indicated_VBN that_IN the_DT failure_NN to_TO detect_VB the_DT ERα_NNP
        does_VBZ not_RB entirely_RB preclude_VB the_DT presence_NN of_IN this_DT receptor_NN in_IN
        human_JJ trophoblast_NN cells_NNS ,_, but_CC might_MD be_VB attributed_VBN to_TO a_DT
        relatively_RB low_JJ number_NN and_CC density_NN of_IN ERα_NNP molecules_NNS on_IN these_DT
        cells_NNS [_NN 17_CD ]_NN ._. On_IN the_DT other_JJ hand_NN ,_, Billiar_NNP et_CC al_NN ._. reported_VBD
        identification_NN of_IN the_DT ERα_NNP in_IN the_DT nuclei_NN of_IN cultured_JJ human_JJ
        placental_NN syncytiotrophoblast_NN [_NN 18_CD ]_NN ._. To_TO our_PRP$ knowledge_NN ,_, no_DT
        western_JJ blot_NN analysis_NN of_IN placental_NN ERα_NNP expression_NN has_VBZ been_VBN
        previously_RB described_VBN ._.
        During_IN the_DT third_JJ trimester_NN ,_, and_CC after_IN 34_CD -_: 36_CD weeks_NNS of_IN
        pregnancy_NN in_IN particular_JJ ,_, the_DT placenta_NN may_MD develop_VB an_DT
        abnormality_NN ,_, often_RB classified_VBN as_IN placental_NN aging_VBG [_NN 19_CD 20_CD 21_CD
        22_CD 23_CD 24_CD ]_NN ._. These_DT abnormal_JJ placentae_NN are_VBP characterized_VBN by_IN
        generalized_JJ interstitial_NN fibrosis_NNS and_CC fibrinoid_NN
        degeneration_NN of_IN villous_JJ stroma_NN ,_, and_CC are_VBP associated_VBN with_IN
        cellular_JJ apoptosis_NNS and_CC congestion_NN of_IN villous_JJ sinusoids_NNS [_NN 24_CD
        25_CD 26_CD 27_CD ]_NN ._. Immunohistochemically_NNP ,_, villous_JJ abnormality_NN is_VBZ
        associated_VBN with_IN progressive_JJ diminution_NN of_IN Thy-_NNP 1_CD
        differentiation_NN protein_NN in_IN the_DT villous_JJ core_NN [_NN 28_CD ]_NN ._. Marked_NNP
        changes_NNS in_IN villous_JJ structure_NN are_VBP particularly_RB associated_VBN
        with_IN advanced_JJ maternal_NN age_NN [_NN 29_CD 30_CD ]_NN ._. We_PRP have_VBP recently_RB
        reported_VBN that_IN ,_, with_IN respect_NN to_TO the_DT Thy-_NNP 1_CD expression_NN ,_,
        compensatory_JJ dilatation_NN of_IN villous_JJ sinusoids_NNS ,_, and_CC placental_NN
        expression_NN of_IN low_JJ molecular_JJ weight_NN cyclin_NN E_NNP variants_NNS ,_, the_DT
        term_NN placentae_NN can_MD be_VB classified_VBN into_IN four_CD placental_NN types_NNS
        (_( PT_NNP 1_CD -_: PT_NNP 4_LS )_) [_NN 30_CD ]_NN ,_, where_WRB PT_NNP 4_CD corresponds_NNS to_TO the_DT most_RBS severe_JJ
        placental_NN abnormality_NN ._. These_DT observations_NNS indicate_VBP that_IN the_DT
        term_NN placenta_NN is_VBZ not_RB a_DT constant_JJ structure_NN ,_, either_CC
        morphologically_RB or_CC biologically_RB ._. Therefore_RB ,_, expression_NN of_IN
        certain_JJ placental_NN proteins_NNS ,_, including_VBG ERα_NNP ,_, may_MD vary_VB ._.
        Upon_IN immunohistochemical_JJ staining_VBG ,_, ERα_NNP is_VBZ predominantly_RB
        localized_VBN to_TO cell_NN nuclei_NN ._. However_RB ,_, positive_JJ staining_VBG of_IN ERα_NNP
        in_IN the_DT cytoplasm_NN can_MD also_RB be_VB seen_VBN [_NN 31_CD 32_CD 33_CD ]_NN ._. It_PRP has_VBZ
        been_VBN reported_VBN that_IN cytoplasmic_JJ ERα_NNP expression_NN accompanied_VBN
        by_IN a_DT lack_NN of_IN nuclear_JJ staining_VBG is_VBZ characteristic_JJ for_IN
        immature_NN cells_NNS ,_, nuclear_JJ ERα_NNP indicates_VBZ differentiating_VBG
        cells_NNS ,_, and_CC complete_JJ lack_NN of_IN ERα_NNP expression_NN accompanies_VBZ
        terminal_NN differentiation_NN of_IN estrogen-sensitive_JJ cells_NNS [_NN 33_CD ]_NN
        ._. In_IN addition_NN ,_, evidence_NN for_IN cell_NN surface_NN ERα_NNP expression_NN has_VBZ
        been_VBN recently_RB presented_VBN [_NN 34_CD ]_NN ._.
        Trophoblast_NNP cells_NNS are_VBP usually_RB separated_JJ and_CC grown_VBN in_IN
        media_NNS containing_VBG phenol_NN red_JJ (_( PhR_NNP )_) [_NN 35_CD ]_NN ._. Phenol_NNP red_NN is_VBZ a_DT
        weak_JJ estrogen_NN with_IN apparent_JJ biological_JJ effects_NNS ,_, and_CC the_DT ERα_NNP
        binding_JJ affinity_NN in_IN Dulbecco_NNP 's_POS Modified_NNP Eagle_NNP 's_POS Medium_NNP
        (_( DMEM_NNP )_) is_VBZ equivalent_JJ to_TO levels_NNS of_IN E_NNP 2_CD as_RB high_JJ as_IN 0_CD ._. 45_CD nM_NN [_NN
        36_CD ]_NN ._. Although_IN relatively_RB low_JJ when_WRB compared_VBN to_TO the_DT E_NNP 2_CD
        levels_NNS in_IN pregnancy_NN ,_, this_DT estrogenic_JJ binding_JJ affinity_NN of_IN
        PhR_NNP is_VBZ close_JJ to_TO that_DT of_IN E_NNP 2_CD during_IN the_DT preovulatory_NN peak_NN [_NN 4_CD
        5_CD ]_NN ._. Therefore_RB ,_, we_PRP included_VBD studies_NNS with_IN PhR_NNP +_NN ,_, PhR-_NNP /_NN E_NNP 2_CD -_:
        and_CC PhR-_NNP /_NN E_NNP 2_CD +_NN media_NNS in_IN order_NN to_TO determine_VB the_DT effect_NN of_IN
        estrogens_NNS on_IN differentiation_NN of_IN cultured_JJ trophoblast_NN cells_NNS
        (_( syncytium_NN formation_NN )_) derived_VBN from_IN normal_JJ and_CC abnormal_JJ
        placental_NN types_NNS ._.
        Here_RB we_PRP show_VBP for_IN the_DT first_JJ time_NN that_IN the_DT ERα_NNP protein_NN is_VBZ
        expressed_VBN in_IN normal_JJ and_CC marginally_RB abnormal_JJ placentae_NN
        (_( normal_JJ placental_NN types_NNS )_) but_CC barely_RB detectable_JJ in_IN placentae_NN
        exhibiting_VBG moderate_JJ and_CC severe_JJ abnormality_NN (_( abnormal_JJ
        placental_NN types_NNS )_) ._. However_RB ,_, all_DT placental_NN types_NNS showed_VBD
        distinct_JJ ERα_NNP expression_NN in_IN trophoblast_NN cultures_NNS ._. Nuclear_NNP
        ERα_NNP expression_NN was_VBD confined_VBN to_TO the_DT villous_JJ and_CC tissue_NN
        culture_NN mononucleated_JJ trophoblast_NN cells_NNS ,_, but_CC not_RB
        syncytiotrophoblast_NN layers_NNS ._. DMEM_NNP with_IN PhR_NNP stimulated_VBN
        differentiation_NN of_IN trophoblast_NN cells_NNS from_IN normal_JJ placental_NN
        types_NNS ,_, but_CC mid-pregnancy_JJ levels_NNS of_IN E_NNP 2_CD significantly_RB
        enhanced_JJ differentiation_NN of_IN cultured_JJ trophoblast_NN cells_NNS
        derived_VBN from_IN both_DT normal_JJ and_CC abnormal_JJ placentae_NN ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          Tissues_NNPS
          Ten_CD placentae_NN from_IN deliveries_NNS between_IN 33_CD and_CC 41_CD weeks_NNS
          of_IN pregnancy_NN were_VBD investigated_VBN ._. The_DT source_NN of_IN placental_NN
          tissue_NN were_VBD women_NNS with_IN normal_JJ and_CC abnormal_JJ pregnancies_NNS
          admitted_VBN to_TO the_DT University_NNP of_IN Tennessee_NNP Medical_NNP Center_NNP ._.
          Six_CD additional_JJ cases_NNS were_VBD studied_VBN for_IN the_DT effect_NN of_IN E_NNP 2_CD on_IN
          trophoblast_NN differentiation_NN ._. Excluded_VBN were_VBD patients_NNS with_IN
          blood_NN transferable_JJ infections_NNS ,_, e_SYM ._. g_SYM ._. ,_, hepatitis_NN and_CC HIV_NNP ,_,
          and_CC apparent_JJ ascendent_NN placental_NN infections_NNS ._. Frozen_NNP
          tissue_NN samples_NNS of_IN ovarian_NN cancer_NN (_( a_DT tissue_NN control_NN for_IN
          ERα_NNP expression_NN )_) were_VBD obtained_VBN from_IN NCI_NNP Cooperative_NNP Human_NNP
          Tissue_NNP Network_NNP ,_, Columbus_NNP ,_, Ohio_NNP ._. MCF-_NNP 7_CD breast_NN carcinoma_NN
          cells_NNS were_VBD maintained_VBN as_IN indicated_VBN previously_RB [_NN 37_CD ]_NN ,_,
          and_CC utilized_JJ as_IN a_DT cell_NN culture_NN positive_JJ control_NN ._. Rat_NNP
          kidneys_NNS for_IN secondary_JJ antibody_NN absorption_NN were_VBD kindly_RB
          supplied_VBN by_IN Dr_NNP ._. Roberto_NNP Dominguez_NNP ,_, Laboratory_NNP of_IN Biology_NNP
          of_IN Reproduction_NNP ,_, Facultad_NNP de_IN Estudios_NNP Profesionales_NNP
          Zaragoza_NNP ,_, UNAM_NNP ,_, Mexico_NNP DF_NNP ,_, Mexico_NNP ._. The_DT study_NN was_VBD approved_VBN
          by_IN the_DT Institutional_NNP Review_NNP Board_NNP ._.
          An_DT unusually_RB detailed_JJ description_NN of_IN the_DT methods_NNS
          utilized_JJ follows_VBZ ,_, since_IN placental_NN ERα_NNP expression_NN is_VBZ still_RB
          a_DT highly_RB controversial_JJ issue_NN ._.
        
        
          Tissue_NNP processing_NN and_CC peroxidase_NN
          immunohistochemistry_NN
          All_DT chemicals_NNS ,_, except_IN where_WRB specified_VBN otherwise_RB ,_, were_VBD
          purchased_VBN from_IN Sigma_NNP Chemical_NNP Co_NNP ._. ,_, St_NNP ._. Louis_NNP ,_, MO_NNP ._. The_DT
          processing_NN of_IN the_DT placenta_NN started_VBD within_IN 30_CD -_: 60_CD min_NN after_IN
          delivery_NN ._. Several_JJ 10_CD ×_NN 10_CD ×_NN 5_CD mm_NN blocks_NNS of_IN tissue_NN were_VBD
          collected_VBN from_IN different_JJ central_JJ cotyledons_NNS into_IN cryomold_NN
          biopsy_NN vinyl_NN specimens_NNS molds_NNS (_( Tissue-_NNP Tek_NNP Cryomold_NNP Biopsy_NNP ,_,
          Miles_NNP Inc_NNP ._. Diagnostic_NNP Division_NNP ,_, Elkhart_NNP ,_, IN_IN )_) and_CC embedded_VBN
          in_IN an_DT optimum_JJ cutting_NN temperature_NN formulation_NN of_IN
          watersoluble_JJ glycols_NNS and_CC resins_NNS (_( O_NNP ._. C_NNP ._. T_NN ._. compound_NN ;_: Miles_NNP )_) ._.
          The_DT molds_NNS with_IN specimens_NNS were_VBD frozen_VBN by_IN floating_VBG on_IN
          liquid_JJ nitrogen_NN and_CC stored_VBD at_IN -_: 80_CD °_NN C_NNP until_IN use_NN ._. Frozen_NNP
          tissues_NNS were_VBD sliced_JJ into_IN 7_CD μm_NN serial_NN sections_NNS using_VBG a_DT
          cryostat_NN microtome_NN with_IN specimen_NN retraction_NN during_IN return_NN
          travel_NN (_( Carl_NNP Zeiss_NNP Microm_NNP HM_NNP 505_CD E_NNP ;_: MICROM_NNP Laborgeräte_NNP
          GmbH_NNP ,_, Waldorf_NNP ,_, Germany_NNP )_) and_CC ten_CD to_TO twelve_CD distinct_JJ tissue_NN
          sections_NNS were_VBD placed_VBN on_IN each_DT slide_NN ._. The_DT slides_NNS were_VBD dried_VBN
          ~_NN 2_CD h_NN at_IN room_NN temperature_NN ,_, fixed_VBD 5_CD min_NN in_IN acetone_NN ,_, dried_VBD
          30_CD min_NN ,_, and_CC stored_VBD at_IN 4_CD °_NN C_NNP until_IN immunoperoxidase_NN staining_VBG
          was_VBD performed_VBN -_: within_IN two_CD to_TO four_CD weeks_NNS ._. Prior_RB to_TO
          staining_VBG ,_, the_DT slides_NNS were_VBD transferred_VBN in_IN a_DT cold_JJ room_NN
          (_( 4_CD °_NN C_NNP )_) into_IN air_NN protected_VBD boxes_NNS containing_VBG Drierite_NNP
          granules_NNS (_( W_NNP ._. A_DT ._. Hammond_NNP Drierite_NNP Co_NNP ,_, Ltd_NNP ,_, Xenia_NNP ,_, OH_NNP )_) to_TO
          prevent_VB water_NN condensation_NN ,_, and_CC the_DT boxes_NNS with_IN slides_NNS
          were_VBD equilibrated_JJ to_TO room_NN temperature_NN before_IN opening_VBG ._.
          Slides_NNS were_VBD incubated_JJ overnight_JJ (_( 4_CD °_NN C_NNP )_) with_IN affinity_NN
          purified_JJ mouse_NN anti-human_JJ ERα_NNP alpha_NN monoclonal_NN antibody_NN
          (_( 1_CD :_: 50_CD ;_: 5_CD μg_NN /_NN ml_NN )_) ,_, clone_NN h-_NN 151_CD ._. This_DT antibody_NN was_VBD raised_VBN
          against_IN a_DT 14_CD residue_NN synthetic_JJ peptide_NN (_( RAANLWPSPLMIKR_NNP )_)
          based_VBN on_IN the_DT human_JJ estrogen_NN receptor_NN (_( residues_NNS 287_CD -_: 300_CD )_) ,_,
          and_CC reacts_VBZ specifically_RB with_IN the_DT activated_VBN 4_CD S_NNP ERα_NNP alpha_NN
          (_( StressGen_NNP Biotechnologies_NNP Corp_NNP ,_, Victoria_NNP ,_, BC_NNP )_) ._.
          Another_DT set_NN of_IN sections_NNS was_VBD similarly_RB incubated_JJ with_IN
          anti-human_JJ ERα_NNP monoclonal_NN antibody_NN (_( ready_JJ to_TO use_VB without_IN
          additional_JJ dilution_NN )_) ,_, clone_NN ID_NNP 5_CD (_( DAKO_NNP Corporation_NNP ,_,
          Carpinteria_NNP ,_, CA_NNP )_) ._. As_IN indicated_VBN by_IN DAKO_NNP ,_, this_DT antibody_NN
          reacts_VBZ with_IN the_DT N_NNP terminal_NN domain_NN (_( A_DT /_NN B_NNP region_NN )_) of_IN the_DT ERα_NNP
          receptor_NN ,_, but_CC the_DT antibody_NN concentration_NN is_VBZ unknown_JJ (_( not_RB
          disclosed_VBN by_IN DAKO_NNP upon_IN request_NN )_) ._. In_IN immunoblotting_VBG ,_, this_DT
          antibody_NN reacts_VBZ with_IN the_DT ~_NN 67_CD kDa_NN polypeptide_NN chain_NN
          obtained_VBN by_IN transformation_NN of_IN E_NNP ._. coli_NNS and_CC transfection_NN of_IN
          COS_NNP cells_NNS with_IN plasmid_NN vectors_NNS expressing_VBG ERα_NNP [_NN 31_CD 32_CD ]_NN
          ._.
          We_PRP also_RB used_VBD monoclonal_NN mouse_NN anti-human_JJ Thy-_NNP 1_CD
          antibody_NN (_( 1_CD :_: 100_CD ;_: 5_CD μg_NN /_NN ml_NN )_) ,_, clone_NN F_NN 15_CD -_: 42_CD -_: 01_CD [_NN 38_CD ]_NN (_( Dr_NNP ._.
          Rosemarie_NNP Dalchau_NNP of_IN the_DT Institute_NNP of_IN Child_NNP Health_NNP ,_,
          University_NNP of_IN London_NNP ,_, London_NNP ,_, England_NNP )_) ,_, for_IN the_DT
          determination_NN of_IN placental_NN type_NN (_( PT_NNP 1_CD -_: PT_NNP 4_CD ,_, see_VBP below_IN )_) ._.
          Control_NNP staining_VBG consisted_VBN of_IN substitution_NN of_IN primary_JJ
          antibody_NN with_IN PBS_NNP ,_, or_CC with_IN 1_CD :_: 50_CD diluted_VBN (_( recommended_VBN by_IN
          the_DT vendor_NN )_) anti-human_JJ CD_NNP 3_CD monoclonal_NN antibody_NN ,_, which_WDT is_VBZ
          directed_VBN against_IN the_DT CD_NNP 3_CD pan_VB T_NN cell_NN marker_NN (_( DAKO_NNP )_) ._. This_DT
          control_NN staining_VBG was_VBD also_RB used_VBN ,_, since_IN the_DT CD_NNP 3_CD antibody_NN
          specifically_RB stains_NNS rare_JJ fetal_JJ T_NN cells_NNS in_IN the_DT placental_NN
          villi_NN only_RB ,_, but_CC not_RB other_JJ villous_JJ structures_NNS ._.
          After_IN several_JJ washes_NNS in_IN PBS_NNP (_( room_NN temperature_NN )_) ,_, the_DT
          sections_NNS were_VBD incubated_JJ with_IN peroxidase_NN labeled_VBD secondary_JJ
          antibody_NN -_: goat_NN anti-mouse_JJ IgG_NNP and_CC IgM_NNP ,_, pre-absorbed_JJ with_IN
          human_JJ serum_NN (_( Jackson_NNP Immunoresearch_NNP ,_, West_NNP Grove_NNP ,_, PA_NNP )_) ,_,
          diluted_VBD 1_CD :_: 50_CD and_CC absorbed_VBN with_IN rat_NN kidney_NN homogenate_NN as_IN
          described_VBN [_NN 39_CD ]_NN ._. Tissue_NNP sections_NNS were_VBD processed_VBN further_RB
          as_IN described_VBN previously_RB [_NN 40_CD ]_NN ,_, including_VBG hematoxylin_NN
          counterstaining_VBG of_IN the_DT nuclei_NN ._.
          Evaluation_NNP was_VBD performed_VBN on_IN a_DT Leitz_NNP DM_NNP RB_NNP (_( Leica_NNP Inc_NNP ._. ,_,
          Wetzlar_NNP ,_, Germany_NNP )_) microscope_NN equipped_VBN with_IN differential_NN
          interference_NN contrast_NN and_CC a_DT DEI-_NNP 470_CD CCD_NNP Video_NNP Camera_NNP
          System_NNP (_( Optronics_NNP Engineering_NNP ,_, Goleta_NNP ,_, CA_NNP )_) with_IN detail_NN
          enhancement_NN ._. The_DT video_NN images_NNS were_VBD captured_VBN by_IN CG-_NNP 7_CD color_NN
          frame_NN grabber_NN (_( Scion_NNP Corporation_NNP ,_, Frederick_NNP ,_, MD_NNP )_)
          supported_VBN by_IN Scion_NNP Image_NN public_JJ software_NN developed_VBN at_IN the_DT
          National_NNP Institutes_NNPS of_IN Health_NNP (_( Wayne_NNP Rasband_NNP ,_, NIH_NNP ,_,
          Bethesda_NNP ,_, MD_NNP )_) ,_, and_CC ported_JJ to_TO Windows_NNP XP_NNP ,_, 2002_CD release_NN
          (_( Microsoft_NNP Corporation_NNP ,_, Redmont_NNP ,_, WA_NNP )_) ._. To_TO obtain_VB figure_NN
          panels_NNS ,_, the_DT captured_VBN video_NN images_NNS were_VBD copied_VBN into_IN
          Microsoft_NNP ®_NN Power-_NNP Point_NNP ®_NN 97_CD SR-_NNP 2_CD (_( Microsoft_NNP Corporation_NNP )_) ._.
          Each_DT image_NN (_( including_VBG controls_NNS )_) was_VBD further_RBR copied_VBN into_IN
          Microsoft_NNP Photo_NNP Editor_NNP 3_CD ._. 0_CD (_( Microsoft_NNP Corporation_NNP )_) ,_, and_CC
          total_JJ saturation_NN balanced_JJ (_( usually_RB brightness_NNS 45_CD ,_,
          contrast_NN 65_CD )_) and_CC optimized_JJ for_IN peroxidase_NN
          immunohistochemistry_NN by_IN decreasing_VBG the_DT image_NN 's_POS blue_JJ
          brightness_NNS and_CC contrast_NN (_( usually_RB to_TO 45_CD )_) and_CC blue_JJ gamma_NN
          (_( usually_RB to_TO 0_CD ._. 83_CD )_) ._.
          For_IN the_DT purpose_NN of_IN statistical_JJ analysis_NN in_IN this_DT study_NN ,_,
          the_DT PT_NNP 1_CD and_CC PT_NNP 2_CD placentae_NN were_VBD coupled_VBN ,_, since_IN they_PRP can_MD be_VB
          considered_VBN as_IN normal_JJ placentae_NN capable_JJ of_IN responding_VBG and_CC
          fulfilling_VBG the_DT demands_NNS of_IN the_DT growing_VBG fetus_NN by_IN
          compensatory_JJ villous_JJ development_NN or_CC expansion_NN of_IN existing_VBG
          mature_VBP villi_NN [_NN 30_CD ]_NN ._. They_PRP were_VBD compared_VBN with_IN placental_NN
          types_NNS showing_VBG moderate_JJ and_CC severe_JJ abnormality_NN (_( coupled_VBN
          PT_NNP 3_CD and_CC PT_NNP 4_LS )_) ._.
        
        
          Tissue_NNP lysates_NNS and_CC western_JJ blot_NN analysis_NN
          For_IN preparation_NN of_IN protein_NN lysates_NNS from_IN placental_NN
          tissue_NN and_CC ovarian_NN cancer_NN for_IN western_JJ blot_NN analysis_NN ,_,
          including_VBG control_NN Cdk_NNP 2_CD and_CC normal_JJ rabbit_NN immunoglobulin_NN
          immunoprecipitates_NNS (_( IP_NNP )_) ,_, 150_CD cryostat_NN tissue_NN sections_NNS
          (_( 7_CD μm_NN )_) were_VBD collected_VBN into_IN microcentrifuge_NN tubes_NNS and_CC lysed_JJ
          by_IN adding_VBG ice-cold_JJ lysis_NNS buffer_NN (_( 20_CD mM_NN Tris_NNP pH_NN 7_CD ._. 5_CD ,_, 200_CD
          mM_NN NaCl_NNP ,_, 0_CD ._. 25_CD %_NN Nonidet_NNP P-_NNP 40_CD ;_: 400_CD μl_NN /_NN 100_CD mg_NN of_IN tissue_NN
          sections_NNS )_) containing_VBG 1_CD mM_NN sodium_NN orthovanadate_NN ,_, 10_CD mM_NN
          sodium_NN fluoride_NN ,_, and_CC 1_CD mM_NN phenylmethylsulfonyl_NN fluoride_NN ._.
          After_IN 15_CD min_NN on_IN ice_NN ,_, the_DT lysates_NNS were_VBD sonicated_JJ using_VBG a_DT
          SonicatorTM_NNP Cell_NNP Disruptor_NNP (_( Heat_NNP Systems-_NNP Ultrasonic_NNP ,_,
          Inc_NNP ._. ,_, Plainview_NNP ,_, NY_NNP )_) for_IN 5_CD seconds_NNS ,_, and_CC centrifuged_JJ at_IN
          11000_CD ×_NN g_SYM for_IN 20_CD min_NN at_IN 4_CD °_NN C_NNP ._. Supernatants_NNP were_VBD stored_VBN at_IN
          minus_CC 80_CD °_NN C_NNP ._. For_IN western_JJ blot_NN analysis_NN ,_, protein_NN
          concentrations_NNS were_VBD determined_VBN by_IN Bradford_NNP assay_NN
          (_( Bio-_NNP Rad_NNP ,_, Hercules_NNP ,_, CA_NNP )_) ._. Equal_NNP amounts_NNS of_IN unboiled_JJ
          protein_NN (_( 42_CD μg_NN )_) were_VBD loaded_VBN onto_IN reducing_VBG 10_CD %_NN
          SDS-Tris-glycine_NNP polyacrylamide_NN gels_NNS ,_, transferred_VBN to_TO
          nitrocellulose_NN (_( Bio-_NNP Rad_NNP )_) ,_, and_CC processed_VBD as_IN described_VBN
          previously_RB [_NN 41_CD ]_NN ,_, with_IN some_DT modifications_NNS ._.
          Briefly_NNP ,_, two_CD identical_JJ membranes_NNS were_VBD washed_VBN in_IN
          Tris-buffered_NNP saline_NN containing_VBG 0_CD ._. 05_CD %_NN Tween_NNP 20_CD (_( TBST_NNP )_) and_CC
          non-specific_JJ binding_JJ sites_NNS were_VBD blocked_VBN by_IN immersing_VBG the_DT
          membrane_NN in_IN blocking_VBG reagent_NN (_( 0_CD ._. 5_LS %_NN casein_NN in_IN TBST_NNP )_) for_IN 1_CD
          hour_NN at_IN room_NN temperature_NN on_IN an_DT orbital_NN shaker_NN ._. After_IN
          blocking_VBG ,_, the_DT membranes_NNS were_VBD briefly_NN rinsed_JJ in_IN two_CD
          changes_NNS of_IN TBST_NNP ,_, and_CC washed_VBD once_RB for_IN 15_CD minutes_NNS and_CC twice_RB
          for_IN 5_CD minutes_NNS in_IN fresh_JJ changes_NNS of_IN TBST_NNP ._. One_CD of_IN two_CD
          identical_JJ membranes_NNS was_VBD first_RB subjected_VBN to_TO overnight_JJ
          incubation_NN (_( 4_CD °_NN C_NNP )_) with_IN blocking_VBG reagent_NN only_RB (_( control_NN )_) ._.
          Another_DT (_( identical_JJ )_) membrane_NN (_( second_JJ membrane_NN )_) was_VBD
          incubated_JJ overnight_JJ (_( 4_CD °_NN C_NNP )_) for_IN ERα_NNP (_( clone_NN h-_NN 151_CD ,_, 0_CD ._. 1_CD
          μg_NN /_NN ml_NN )_) in_IN blocking_VBG reagent_NN ._. Next_JJ the_DT membranes_NNS were_VBD
          washed_VBN and_CC incubated_JJ with_IN peroxidase_NN labeled_VBD secondary_JJ
          antibody_NN -_: goat_NN anti-mouse_JJ IgG_NNP and_CC IgM_NNP (_( Jackson_NNP
          Immunoresearch_NNP )_) diluted_VBN 1_CD :_: 2000_CD -_: for_IN 1_CD hour_NN at_IN room_NN
          temperature_NN ._. Before_IN staining_VBG ,_, the_DT secondary_JJ antibody_NN was_VBD
          diluted_VBN 1_CD :_: 60_CD (_( 5_CD μl_NN /_NN 300_CD μl_NN )_) ,_, absorbed_VBN with_IN rat_NN kidney_NN
          homogenate_NN (_( 150_CD μg_NN /_NN 300_CD μl_NN )_) for_IN 20_CD min_NN ,_, centrifuged_JJ and_CC
          diluted_VBN to_TO the_DT final_JJ concentration_NN 1_CD :_: 2000_CD ._. This_DT
          absorption_NN eliminated_VBD any_DT non-specific_JJ background_NN ._. After_IN
          incubation_NN ,_, the_DT membranes_NNS were_VBD washed_VBN 1_CD ×_NN 15_CD min_NN ,_, 2_CD ×_NN 10_CD
          min_NN and_CC 4_CD ×_NN 5_CD min_NN in_IN fresh_JJ changes_NNS of_IN TBST_NNP ,_, and_CC incubated_JJ
          for_IN 1_CD hour_NN in_IN blocking_VBG buffer_NN at_IN room_NN temperature_NN ._. Bound_NNP
          antibodies_NNS were_VBD detected_VBN by_IN a_DT chemiluminescent_NN detection_NN
          system_NN (_( ECL_NNP ;_: Amersham_NNP Pharmacia_NNP Biotech_NNP ,_, Piscataway_NNP ,_, NJ_NNP )_)
          as_IN recommended_VBN by_IN the_DT manufacturer_NN 's_POS protocol_NN ._. For_IN
          exposure_NN (_( 1_CD min_NN ,_, 5_CD min_NN ,_, and_CC up_IN to_TO 1_CD h_NN )_) we_PRP used_VBD Kodak_NNP XAR_NNP
          film_NN (_( Eastman_NNP Kodak_NNP ,_, Rochester_NNP ,_, NY_NNP )_) ._.
          Next_JJ ,_, the_DT membranes_NNS were_VBD stripped_VBN in_IN buffer_NN containing_VBG
          0_CD ._. 2_CD M_NNP glycine_NN (_( pH_NN 2_CD ._. 2_CD ._. )_) ,_, 0_CD ._. 1_CD %_NN SDS_NNP ,_, and_CC 1_CD ._. 0_CD %_NN Tween_NNP 20_CD for_IN
          45_CD min_NN ,_, washed_VBN ,_, and_CC reprobed_JJ with_IN antibodies_NNS raised_VBD
          against_IN other_JJ proteins_NNS of_IN interest_NN ,_, e_SYM ._. g_SYM ._. ,_, the_DT first_JJ
          membrane_NN with_IN ERα_NNP antibody_NN ID_NNP 5_CD (_( DAKO_NNP )_) and_CC the_DT second_JJ
          membrane_NN with_IN actin_NN mouse_NN monoclonal_NN antibody_NN ,_, clone_NN C_NNP 4_CD
          (_( Boehringer_NNP Mannheim_NNP Corp_NNP ._. ,_, Indianapolis_NNP ,_, IN_IN )_) 0_CD ._. 25_CD μg_NN /_NN ml_NN ._.
          As_IN indicated_VBD above_IN ,_, the_DT ID_NNP 5_CD antibody_NN is_VBZ delivered_VBN ready_JJ
          to_TO use_VB for_IN immunohistochemistry_NN ,_, yet_RB the_DT antibody_NN
          concentration_NN is_VBZ unknown_JJ ._. For_IN western_JJ blot_NN analysis_NN we_PRP
          diluted_VBD the_DT ID_NNP 5_CD antibody_NN 1_CD :_: 50_CD ._. Although_IN the_DT ID_NNP 5_CD antibody_NN
          identified_VBD a_DT band_NN similar_JJ to_TO that_DT detected_VBN by_IN h-_NN 151_CD ,_, the_DT
          staining_VBG was_VBD weaker_JJR (_( see_VB Fig_NNP ._. 1_LS )_) ._. Therefore_RB ,_, higher_JJR ID_NNP 5_CD
          antibody_NN concentration_NN might_MD be_VB required_VBN for_IN optimum_JJ
          outcomes_NNS in_IN western_JJ blot_NN analysis_NN ._.
        
        
          Immunoprecipitates_NNP (_( IP_NNP )_)
          Cdk_NNP 2_CD and_CC rabbit_NN IgG_NNP IP_NNP were_VBD utilized_JJ as_IN negative_JJ
          controls_NNS for_IN ERα_NNP antibodies_NNS ._. Staining_NNP for_IN cyclin_NN E_NNP ,_, clone_NN
          HE_PRP 12_CD (_( PharMingen_NNP ,_, San_NNP Diego_NNP ,_, CA_NNP )_) ,_, served_VBD as_IN a_DT positive_JJ
          Cdk_NNP 2_CD IP_NNP control_NN ._. For_IN Cdk_NNP 2_CD IP_NNP ,_, the_DT Cdk_NNP 2_CD (_( M_NNP 2_LS )_) affinity_NN
          purified_JJ rabbit_NN polyclonal_NN antibody_NN raised_VBD against_IN a_DT
          peptide_NN mapping_NN at_IN the_DT carboxy_NN terminus_JJ of_IN Cdk_NNP 2_CD of_IN human_JJ
          origin_NN (_( Santa_NNP Cruz_NNP Biotechnology_NNP ,_, Santa_NNP Cruz_NNP ,_, CA_NNP )_) was_VBD
          utilized_JJ ._. Equal_NNP amounts_NNS (_( 200_CD μg_NN )_) of_IN protein_NN from_IN each_DT
          sample_NN were_VBD immunoprecipitated_JJ with_IN 0_CD ._. 5_CD μg_NN Cdk_NNP 2_CD antibody_NN
          in_IN 300_CD μl_NN IP_NNP buffer_NN (_( 50_CD mM_NN Tris_NNP ,_, pH_NN 7_CD ._. 5_CD ;_: 5_CD mM_NN EDTA_NNP ,_, 20_CD mM_NN
          glycerol_NN ,_, 150_CD mM_NN NaCl_NNP ,_, 1_CD %_NN NP-_NNP 40_CD )_) and_CC 25_CD μl_NN protein_NN A_DT /_NN G_NNP
          agarose_NN beads_NNS (_( Santa_NNP Cruz_NNP Biotechnology_NNP )_) on_IN an_DT orbital_NN
          shaker_NN overnight_JJ at_IN 4_CD °_NN C_NNP ._.
          For_IN IP_NNP control_NN ,_, 0_CD ._. 5_CD μg_NN of_IN normal_JJ rabbit_NN IgG_NNP was_VBD used_VBN
          instead_RB of_IN anti-_NN Cdk_NNP 2_CD rabbit_NN polyclonal_NN antibody_NN ._.
          Immunoprecipitates_NNP were_VBD collected_VBN by_IN centrifugation_NN
          (_( 11000_CD ×_NN g_SYM for_IN 10_CD min_NN at_IN 4_CD °_NN C_NNP )_) ,_, washed_VBD three_CD times_NNS with_IN
          500_CD μl_NN TG-buffer_NNP containing_VBG 20_CD mM_NN Tris_NNP ,_, 250_CD mM_NN NaCl_NNP ,_, and_CC
          0_CD ._. 5_CD %_NN NP-_NNP 40_CD ._. For_IN western_JJ blot_NN analysis_NN ,_, IP_NNP were_VBD
          resuspended_JJ in_IN 20_CD μl_NN 2_CD ×_NN SDS_NNP /_NN sample_NN (_( Laemmli_NNP )_) buffer_NN and_CC
          the_DT supernatants_NNS were_VBD resolved_VBN by_IN SDS-PAGE_NNP ._. Cyclin_NNP E_NNP
          variants_NNS in_IN Cdk_NNP 2_CD IP_NNP were_VBD detected_VBN by_IN probing_VBG with_IN HE_PRP 12_CD
          primary_JJ antibody_NN (_( PharMingen_NNP )_) ,_, followed_VBN by_IN goat_NN
          anti-mouse_JJ IgG_NNP and_CC IgM_NNP (_( Jackson_NNP Immunoresearch_NNP )_) secondary_JJ
          antibody_NN conjugated_JJ with_IN horse_NN radish_NN peroxidase_NN ,_, and_CC
          visualized_JJ by_IN a_DT chemiluminescent_NN detection_NN system_NN (_( ECL_NNP ,_,
          Amersham_NNP Pharmacia_NNP Biotechnology_NNP )_) and_CC autoradiography_NN as_IN
          indicated_VBN above_IN ._. Next_JJ ,_, the_DT membranes_NNS were_VBD stripped_VBN and_CC
          probed_JJ with_IN h-_NN 151_CD ERα_NNP antibody_NN as_IN indicated_VBN above_IN ._. In_IN
          parallel_JJ ,_, the_DT western_JJ blots_NNS with_IN original_JJ protein_NN lysates_NNS
          were_VBD processed_VBN -_: see_VB Fig_NNP ._. 2_LS ._.
        
        
          Cell_NNP separation_NN &_CC culture_NN
          Placental_NNP tissue_NN was_VBD digested_VBN and_CC trophoblast_NN cells_NNS
          isolated_VBN and_CC cultured_JJ as_IN described_VBN previously_RB [_NN 41_CD ]_NN ,_,
          with_IN modifications_NNS ._. Since_IN the_DT first_JJ digestion_NN yielded_VBD
          only_RB erythrocytes_NNS and_CC some_DT white_JJ blood_NN cells_NNS and_CC in_IN the_DT
          second_JJ digestion_NN such_JJ cells_NNS were_VBD accompanied_VBN by_IN only_RB rare_JJ
          trophoblast_NN cells_NNS ,_, the_DT third_JJ supernatant_NN was_VBD the_DT first_JJ to_TO
          be_VB collected_VBN ._. The_DT remaining_VBG tissue_NN was_VBD incubated_JJ 30_CD min_NN
          at_IN 37_CD °_NN C_NNP in_IN 50_CD ml_NN of_IN normal_JJ DMEM_NNP (_( PhR_NNP +_NN )_) containing_VBG 25_CD mM_NN
          HEPES_NNP and_CC 4500_CD mg_NN /_NN L_NNP glucose_NN (_( DMEM-HG_NNP )_) ,_, without_IN trypsin_NN
          and_CC DNase_NNP [_NN 42_CD ]_NN ._. The_DT supernatant_NN was_VBD collected_VBN and_CC the_DT
          procedure_NN repeated_VBN ._. Collected_NNP cells_NNS were_VBD pooled_VBN ,_, washed_VBD
          twice_RB in_IN DMEM-HG_NNP ,_, diluted_VBN to_TO 10_CD ml_NN in_IN DMEM-HG_NNP
          supplemented_JJ with_IN heat_NN inactivated_JJ 5_CD %_NN fetal_JJ bovine_JJ serum_NN
          (_( FBS_NNP ;_: Gibco_NNP /_NN BRL_NNP )_) and_CC antibiotics_NNS (_( 50_CD μg_NN /_NN ml_NN gentamycin_NN ,_,
          100_CD U_NNP /_NN ml_NN penicillin_NN ,_, and_CC 100_CD μg_NN /_NN ml_NN streptomycin_NN )_) ,_, and_CC
          viable_JJ large_JJ nucleated_JJ cells_NNS (_( 95_CD %_NN in_IN trypan_NN blue_JJ
          exclusion_NN test_NN )_) were_VBD counted_VBN ._. The_DT procedure_NN gave_VBD between_IN
          30_CD -_: 40_CD ×_NN 10_CD 6_CD viable_JJ trophoblast_NN cells_NNS /_NN 35_CD g_SYM of_IN
          placental_NN tissue_NN ._. Cells_NNP were_VBD seeded_VBN in_IN 60_CD mm_NN Falcon_NNP
          Primaria_NNP petris_NNS (_( Fisher_NNP Scientific_NNP ,_, Pittsburgh_NNP ,_, PA_NNP )_) ,_, in_IN
          the_DT amount_NN of_IN 7_CD ×_NN 10_CD 6_CD per_IN dish_NN cells_NNS in_IN 3_CD ml_NN DMEM-HG_NNP with_IN
          5_CD %_NN FBS_NNP +_NN antibiotics_NNS as_IN above_IN ,_, and_CC cultured_JJ in_IN an_DT
          humidified_JJ atmosphere_NN with_IN 5_CD %_NN CO_NNP 
          2_CD at_IN 37_CD °_NN C_NNP ._. Cells_NNP were_VBD harvested_VBN for_IN
          protein_NN at_IN 16_CD -_: 24_CD h_NN (_( early_JJ cultures_NNS )_) and_CC at_IN 72_CD to_TO 96_CD h_NN
          (_( late_JJ cultures_NNS )_) ._. The_DT medium_NN was_VBD changed_VBN every_DT 24_CD hours_NNS ._.
          During_IN cultivation_NN the_DT differentiation_NN of_IN syncytium_NN from_IN
          cytotrophoblast_NN cells_NNS was_VBD monitored_VBN daily_JJ ,_, and_CC video_NN
          images_NNS from_IN several_JJ fields_NNS were_VBD stored_VBN in_IN the_DT computer_NN
          for_IN additional_JJ evaluation_NN and_CC presentation_NN ._. To_TO prepare_VB
          cell_NN lysates_NNS ,_, cultures_NNS were_VBD washed_VBN twice_RB with_IN ice-cold_JJ
          PBS_NNP ,_, lysed_JJ by_IN adding_VBG ice-cold_JJ lysis_NNS buffer_NN ,_, and_CC stored_VBD
          and_CC processed_VBN for_IN western_JJ blot_NN analysis_NN as_IN indicated_VBN for_IN
          tissue_NN lysates_NNS above_IN ._.
          Along_IN with_IN cultures_NNS in_IN petri_NN dishes_NNS ,_, we_PRP established_VBD
          cultures_NNS in_IN LabTek_NNP II_NNP 4_CD -_: well_RB glass_NN slides_NNS (_( Nalgene_NNP Nunc_NNP
          International_NNP ,_, Naperville_NNP ,_, Illinois_NNP )_) ._. The_DT slide_NN chambers_NNS
          were_VBD pre-coated_JJ with_IN 80_CD μg_NN /_NN ml_NN of_IN calf_NN skin_NN collagen_NN
          dissolved_VBN in_IN 0_CD ._. 15_CD %_NN NaCl_NNP with_IN 50_CD μg_NN /_NN ml_NN gentamycin_NN ._. Slides_NNS
          were_VBD incubated_JJ with_IN 500_CD μl_NN of_IN collagen_NN solution_NN per_IN
          chamber_NN for_IN 72_CD h_NN at_IN 37_CD °_NN C_NNP ,_, dried_VBD for_IN 2_CD h_NN in_IN an_DT air_NN flow_NN
          box_NN ,_, and_CC stored_VBD in_IN the_DT original_JJ (_( UV_NNP sterilized_VBN and_CC air_NN
          protected_VBN )_) package_NN at_IN 4_CD °_NN C_NNP prior_RB use_NN ._. The_DT slide_NN chambers_NNS
          were_VBD seeded_VBN with_IN 4_CD ×_NN 10_CD 5_CD cells_NNS per_IN well_RB ,_, and_CC utilized_JJ for_IN
          immunohistochemical_JJ evaluation_NN of_IN ERα_NNP expression_NN during_IN
          trophoblast_NN differentiation_NN (_( Fig_NNP ._. 4_LS )_) ._.
        
        
          Amnion_NNP fibroblast_NN cell_NN culture_NN
          Amnion_NNP was_VBD carefully_RB separated_JJ from_IN the_DT chorion_NN laeve_NN ,_,
          placed_VBN into_IN dry_JJ petri_NN dishes_NNS with_IN epithelium_NN facing_VBG the_DT
          bottom_NN ,_, allowed_VBN to_TO adhere_VB in_IN the_DT incubator_NN for_IN 1_CD h_NN at_IN
          37_CD °_NN C_NNP ,_, cut_VB into_IN narrow_JJ strips_NNS ,_, and_CC incubated_JJ for_IN seven_CD to_TO
          nine_CD days_NNS in_IN the_DT same_JJ medium_NN used_VBN for_IN trophoblast_NN
          cultures_NNS ,_, with_IN daily_JJ monitoring_NN of_IN fibroblast_NN outgrowth_NN ._.
          The_DT amnion_NN was_VBD then_RB removed_VBN and_CC fibroblasts_NNS harvested_VBN
          after_IN reaching_VBG ~_NN 80_CD %_NN confluence_NN ,_, and_CC processed_VBD for_IN western_JJ
          blot_NN analysis_NN ._. Some_DT fibroblasts_NNS were_VBD passaged_JJ as_IN
          described_VBN for_IN other_JJ cell_NN types_NNS [_NN 37_CD ]_NN ,_, seeded_VBN onto_IN
          four-chamber_JJ slides_NNS ,_, allowed_VBN to_TO reach_VB similar_JJ confluence_NN ,_,
          and_CC processed_VBD for_IN immunohistochemistry_NN with_IN primary_JJ
          antibodies_NNS to_TO fibroblast_NN markers_NNS ._. All_DT cells_NNS exhibited_VBN
          staining_VBG for_IN Thy-_NNP 1_CD fibroblast_NN differentiation_NN protein_NN ,_,
          vimentin_NN and_CC alpha_NN actin_NN ,_, and_CC no_DT staining_VBG with_IN leukocyte_NN
          common_JJ antigen_NN antibody_NN (_( negative_JJ control_NN )_) -_: data_NNS not_RB
          shown_VBN ._.
        
        
          Quantitative_NNP analysis_NN of_IN ERα_NNP expression_NN in_IN western_JJ
          blots_NNS and_CC extent_NN of_IN syncytium_NN formation_NN
          Scanned_NNP ERα_NNP bands_NNS from_IN western_JJ blots_NNS were_VBD imported_VBN
          into_IN the_DT Paint_NNP Shop_NNP Pro_FW version_NN 5_CD ._. 0_CD (_( Jasc_NNP Software_NNP ,_, Inc_NNP ._. ,_,
          Minneapolis_NNP ,_, MN_NNP )_) ,_, saved_VBN in_IN Windows_NNP Bitmap_NNP ,_, and_CC loaded_VBD
          into_IN Scion_NNP Image_NN (_( Scion_NNP Corporation_NNP )_) ._. Loaded_NNP images_NNS were_VBD
          enlarged_JJ 16_CD ×_NN ,_, and_CC six_CD 40_CD square_JJ pixel_NN rectangle_NN areas_NNS
          were_VBD measured_VBN above_IN (_( background_NN )_) and_CC within_IN each_DT band_NN
          (_( crude_NN values_NNS )_) ._. The_DT measurements_NNS were_VBD copied_VBN into_IN
          Microsoft_NNP Excel_NNP 2002_CD (_( Microsoft_NNP Corporation_NNP )_) ,_, and_CC
          background_NN values_NNS subtracted_VBN from_IN crude_NN measurements_NNS to_TO
          obtain_VB net_JJ optical_JJ density_NN (_( O_NNP ._. D_NNP ._. )_) ._. Net_JJ values_NNS were_VBD
          utilized_JJ for_IN statistical_JJ calculations_NNS ._.
          Extent_NNP of_IN syncytium_NN formation_NN in_IN PhR_NNP and_CC E_NNP 2_CD
          experiments_NNS (_( see_VB next_JJ paragraph_NN )_) was_VBD evaluated_VBN by_IN a_DT
          measurement_NN of_IN the_DT area_NN occupied_VBN by_IN individual_JJ clusters_NNS ._.
          The_DT video_NN images_NNS of_IN clusters_NNS in_IN tissue_NN cultures_NNS (_( six_CD
          representative_NN fields_NNS per_IN time_NN /_NN data_NNS point_VBP )_) were_VBD saved_VBN in_IN
          Windows_NNP Bitmap_NNP ,_, and_CC loaded_VBD into_IN Scion_NNP Image_NN (_( Scion_NNP
          Corporation_NNP )_) ._. Individual_JJ clusters_NNS were_VBD encircled_JJ using_VBG
          free_JJ hand_NN tool_NN ,_, and_CC the_DT area_NN of_IN each_DT cluster_NN measured_VBN ._.
          Clusters_NNP exceeding_VBG the_DT view_NN area_NN (_( 90000_CD sq_NN μm_NN )_) were_VBD
          evaluated_VBN as_IN the_DT maximum_NN area_NN size_NN (_( 90000_CD )_) ._. Measurements_NNP
          of_IN six_CD clusters_NNS were_VBD utilized_JJ for_IN statistical_JJ evaluation_NN
          of_IN each_DT culture_NN at_IN a_DT given_VBN time_NN ._.
        
        
          Effect_NN of_IN PhR_NNP and_CC E_NNP 2_CD on_IN trophoblast_NN
          differentiation_NN
          Six_CD additional_JJ cases_NNS were_VBD studied_VBN for_IN the_DT extent_NN of_IN
          syncytium_NN formation_NN under_IN various_JJ estrogen_NN influences_NNS ._.
          Cells_NNP were_VBD grown_VBN in_IN complete_JJ DMEM-HG_NNP ,_, which_WDT contains_VBZ 45_CD
          μM_NN phenol_NN red_JJ (_( PhR_NNP +_NN )_) ._. Phenol_NNP red_JJ binds_NNS to_TO the_DT ERα_NNP with_IN an_DT
          affinity_NN 0_CD ._. 001_CD %_NN that_IN of_IN E_NNP 2_CD (_( 100_CD %_NN )_) [_NN 36_CD ]_NN ._. Hence_RB ,_, the_DT
          binding_JJ affinity_NN of_IN 45_CD μM_NN PhR_NNP is_VBZ equivalent_JJ to_TO 45_CD μM_NN ×_NN 10_CD
          -_: 5_CD ,_, i_NNP ._. e_SYM ._. 0_CD ._. 45_CD nM_NN E_NNP 2_CD ._. Other_JJ media_NNS were_VBD phenol_NN red-free_JJ
          DMEM-HG_NNP without_IN estrogens_NNS (_( PhR-_NNP /_NN E_NNP 2_CD -_: )_) ,_, or_CC phenol_NN red-free_JJ
          DMEM-HG_NNP with_IN 20_CD nM_NN E_NNP 2_CD (_( PhR-_NNP /_NN E_NNP 2_CD +_NN )_) ._. This_DT concentration_NN of_IN
          E_NNP 2_CD corresponds_NNS to_TO mid-pregnancy_JJ E_NNP 2_CD levels_NNS [_NN 5_CD ]_NN ._. Each_DT
          medium_NN was_VBD supplemented_JJ with_IN 5_CD %_NN heat-inactivated_JJ FBS_NNP ._. The_DT
          PhR-_NNP /_NN E_NNP 2_CD +_NN medium_NN was_VBD prepared_VBN as_RB previously_RB described_VBD [_NN 37_CD
          ]_NN ._. Samples_NNP were_VBD harvested_VBN at_IN time_NN 0_CD (_( just_RB after_IN
          separation_NN of_IN cells_NNS )_) ,_, and_CC from_IN the_DT early_JJ (_( 16_CD -_: 24_CD h_NN )_) and_CC
          late_JJ cultures_NNS (_( 72_CD -_: 96_CD h_NN )_) ._.
        
        
          Statistics_NNS
          Statistical_NNP analysis_NN of_IN data_NNS was_VBD performed_VBN using_VBG
          GraphPad_NNP InStat_NNP version_NN 3_CD ._. 01_CD for_IN Windows_NNP software_NN
          (_( GraphPad_NNP Software_NNP ,_, San_NNP Diego_NNP ,_, CA_NNP )_) ._. For_IN evaluation_NN of_IN ERα_NNP
          expression_NN density_NN ,_, the_DT net_JJ O_NNP ._. D_NNP ._. values_NNS were_VBD transformed_VBN
          (_( 
          Y_NNP =_SYM Log_NNP [_NN 
          Y_NNP ]_NN )_) and_CC subjected_VBN to_TO
          Kruskal-_NNP Wallis_NNP Test_NNP (_( Nonparametric_NNP ANOVA_NNP )_) ,_, followed_VBN by_IN
          Dunn_NNP 's_POS Multiple_NNP Comparisons_NNP Test_NNP ._. Probability_NNP values_NNS of_IN 
          P_NN <_NN 0_CD ._. 05_CD were_VBD considered_VBN
          significant_JJ ._. Area_NNP of_IN syncytial_NN aggregates_NNS was_VBD similarly_RB
          evaluated_VBN ._.
        
      
      
        Results_NNS
        
          Control_NN studies_NNS -_: western_JJ blot_NN analysis_NN and_CC
          immunoprecipitates_NNS (_( Figures_NNS 1_CD and_CC 2_LS )_)
          Figure_NN 1_CD shows_VBZ ERα_NNP protein_NN expression_NN at_IN ~_NN 65_CD kDa_NN
          detected_VBD with_IN two_CD ERα_NNP monoclonal_NN antibodies_NNS in_IN an_DT
          amniotic_JJ fibroblast_NN culture_NN (_( FBC_NNP ,_, lane_NN 1_LS )_) ,_, MCF-_NNP 7_CD cells_NNS
          (_( MCF_NNP ,_, lane_NN 2_LS )_) and_CC a_DT trophoblast_NN culture_NN (_( TRC_NNP ,_, lane_NN 3_LS )_) ._.
          The_DT last_JJ lane_NN is_VBZ from_IN an_DT ovarian_NN adenocarcinoma_NN tissue_NN
          sample_NN (_( AOvCa_NNP )_) ._. Since_IN the_DT h-_NN 151_CD antibody_NN clone_NN gave_VBD a_DT
          stronger_JJR reaction_NN ,_, it_PRP has_VBZ been_VBN utilized_JJ in_IN western_JJ blot_NN
          analysis_NN throughout_IN the_DT remainder_NN of_IN this_DT study_NN ._. In_IN Fig_NNP ._.
          2_LS ,_, the_DT h-_NN 151_CD antibody_NN identifies_VBZ an_DT ERα_NNP band_NN in_IN cultured_JJ
          trophoblast_NN cells_NNS and_CC ovarian_NN endometrioid_NN carcinoma_NN
          (_( EOvCa_NNP )_) lysates_NNS (_( lanes_NNS 1_CD and_CC 2_LS )_) ,_, but_CC no_DT reactivity_NN is_VBZ
          apparent_JJ in_IN rabbit_NN anti-_NN Cdk_NNP 2_CD IP_NNP (_( lanes_NNS 3_CD and_CC 5_LS )_) ._. The_DT HE_PRP 12_CD
          anti-cyclin_JJ E_NNP antibody_NN was_VBD utilized_JJ as_IN a_DT positive_JJ control_NN
          for_IN Cdk_NNP 2_CD IP_NNP ._. Immunoprecipitate_NNP with_IN normal_JJ rabbit_NN
          immunoglobulin_NN (_( lane_NN 4_LS )_) served_VBD as_IN a_DT negative_JJ IP_NNP
          control_NN ._.
        
        
          Placental_NNP types_NNS (_( Table_NNP 1_LS )_)
          During_IN the_DT last_JJ trimester_NN of_IN human_JJ pregnancy_NN ,_, the_DT
          placenta_NN may_MD exhibit_VB pronounced_VBD abnormality_NN associated_VBN
          with_IN generalized_JJ villous_JJ degeneration_NN ,_, often_RB called_VBN
          placental_NN aging_NN or_CC senescence_NN [_NN 22_CD 23_CD 24_CD 27_CD 43_CD 44_CD 45_CD ]_NN ._.
          We_PRP have_VBP recently_RB shown_VBN that_DT placental_NN abnormality_NN is_VBZ
          associated_VBN with_IN the_DT diminution_NN of_IN Thy-_NNP 1_CD differentiation_NN
          protein_NN immunostaining_VBG in_IN the_DT villous_JJ core_NN and_CC less_JJR or_CC
          more_RBR pronounced_JJ dilatation_NN of_IN villous_JJ sinusoids_NNS ._. Based_VBN on_IN
          these_DT two_CD criteria_NNS ,_, accompanied_VBN by_IN changes_NNS in_IN the_DT
          expression_NN of_IN cyclin_NN E_NNP (_( cE_NN )_) low_JJ molecular_JJ weight_NN protein_NN
          variants_NNS ,_, four_CD basic_JJ placental_NN types_NNS can_MD be_VB recognized_VBN
          (_( PT_NNP 1_CD -_: PT_NNP 4_CD ,_, Table_NNP 1_LS )_) ._.
          Normal_NNP mature_VBP placentae_NN ,_, placental_NN type_NN 1_CD (_( PT_NNP 1_LS )_) ,_, show_NN
          strong_JJ Thy-_NNP 1_CD expression_NN in_IN the_DT villous_JJ core_NN ,_, and_CC
          relatively_RB small_JJ lumen_NN of_IN sinusoids_NNS ;_: expression_NN of_IN cE_NN
          variants_NNS is_VBZ low_JJ ._. The_DT PT_NNP 1_CD can_MD be_VB viewed_VBN as_IN placenta_NN
          capable_JJ of_IN fulfilling_VBG the_DT demands_NNS of_IN the_DT growing_VBG fetus_NN
          (_( occasional_JJ villous_JJ regeneration_NN and_CC expansion_NN of_IN
          existing_VBG mature_VBP villi_NN )_) ,_, without_IN requirement_NN of_IN adaptive_JJ
          dilatation_NN of_IN villous_JJ sinusoids_NNS ._.
          Marginal_JJ irregularity_NN ,_, the_DT PT_NNP 2_CD ,_, is_VBZ characterized_VBN by_IN
          significant_JJ diminution_NN of_IN Thy-_NNP 1_CD staining_VBG ,_, and_CC moderate_JJ
          but_CC significant_JJ dilatation_NN of_IN villous_JJ sinusoids_NNS ._. Cyclin_NNP E_NNP
          expression_NN is_VBZ highest_JJS in_IN this_DT placental_NN type_NN ._. The_DT PT_NNP 2_CD can_MD
          be_VB viewed_VBN as_IN placentae_NN with_IN villous_JJ and_CC vascular_NN
          adaptation_NN to_TO imminent_JJ placental_NN aging_VBG (_( enhanced_VBN villous_JJ
          regeneration_NN and_CC expansion_NN ,_, accompanied_VBN by_IN moderate_JJ
          dilatation_NN of_IN villous_JJ sinusoids_NNS )_) ._.
          Placentae_NNP showing_VBG further_JJ diminution_NN of_IN Thy-_NNP 1_CD
          expression_NN and_CC excessive_JJ dilatation_NN of_IN villous_JJ sinusoids_NNS
          are_VBP classified_VBN as_IN PT_NNP 3_CD ._. Cyclin_NNP E_NNP expression_NN is_VBZ higher_JJR
          compared_VBN to_TO PT_NNP 1_CD but_CC lower_JJR compared_VBN to_TO PT_NNP 2_CD ._. The_DT PT_NNP 3_CD can_MD be_VB
          viewed_VBN as_IN placentae_NN exhibiting_VBG advanced_VBN aging_VBG ,_, capable_JJ of_IN
          compensating_VBG demands_NNS of_IN the_DT growing_VBG fetus_NN only_RB by_IN extreme_JJ
          dilatation_NN of_IN villous_JJ blood_NN sinusoids_NNS ._.
          Finally_RB ,_, in_IN PT_NNP 4_CD ,_, Thy-_NNP 1_CD expression_NN in_IN terminal_NN villi_NN is_VBZ
          very_RB low_JJ ,_, but_CC this_DT is_VBZ not_RB accompanied_VBN by_IN dilatation_NN of_IN
          villous_JJ sinusoids_NNS ._. Cyclin_NNP E_NNP expression_NN varies_VBZ ._. The_DT PT_NNP 4_CD
          can_MD be_VB viewed_VBN as_IN placentae_NN exhibiting_VBG villous_JJ immaturity_NN ,_,
          either_CC compensated_VBN by_IN placental_NN hypertrophy_NN (_( villous_JJ
          regeneration_NN and_CC expansion_NN without_IN maturation_NN -_: maternal_NN
          diabetes_NN mellitus_JJ ;_: PT_NNP 4_CD A_DT )_) ,_, or_CC uncompensated_JJ (_( placental_NN
          atrophy_NN associated_VBN with_IN villous_JJ immaturity_NN -_: intrauterine_JJ
          growth_NN retardation_NN ;_: PT_NNP 4_CD B_NNP )_) with_IN apparent_JJ consequences_NNS for_IN
          the_DT newborn_JJ ._. Further_RB details_NNS are_VBP given_VBN in_IN Ref_NNP [_NN 30_CD ]_NN
          ._.
          Altogether_RB ,_, placental_NN abnormality_NN is_VBZ not_RB as_RB simple_JJ as_IN
          one_PRP might_MD imagine_VB ,_, e_SYM ._. g_SYM ._. just_RB placental_NN aging_NN ._. Table_NNP
          1_CD shows_VBZ that_IN abnormal_JJ placentae_NN include_VBP either_CC advanced_VBN
          placental_NN aging_VBG with_IN an_DT excess_NN of_IN villous_JJ blood_NN sinusoid_NN
          dilatation_NN (_( PT_NNP 3_LS )_) or_CC severe_JJ villous_JJ immaturity_NN without_IN
          significant_JJ dilatation_NN of_IN villous_JJ sinusoids_NNS (_( PT_NNP 4_LS )_) ._. Again_RB ,_,
          the_DT latter_NN can_MD be_VB either_CC compensated_VBN by_IN placental_NN
          hypertrophy_NN (_( normal_JJ Apgars_NNP associated_VBN with_IN fetal_JJ
          macrosomia_NN in_IN maternal_NN diabetes_NN ;_: PT_NNP 4_CD A_DT )_) ,_, or_CC uncompensated_JJ
          (_( placental_NN hypotrophy_NN )_) and_CC associated_VBN with_IN intrauterine_JJ
          growth_NN retardation_NN and_CC apparent_JJ deterioration_NN of_IN the_DT
          Apgar_NNP scores_NNS [_NN 30_CD ]_NN (_( PT_NNP 4_CD B_NNP )_) ._.
          Note_VB that_IN the_DT Table_NNP 1_CD also_RB summarizes_NNS the_DT data_NNS with_IN
          respect_NN to_TO ERα_NNP expression_NN showing_NN either_CC strong_JJ
          expression_NN of_IN ERα_NNP protein_NN (_( PT_NNP 1_CD and_CC PT_NNP 2_LS )_) or_CC only_RB traces_VBZ
          (_( PT_NNP 3_CD and_CC PT_NNP 4_LS )_) ._. This_DT supports_VBZ a_DT view_NN that_IN ,_, regardless_RB of_IN
          pathophysiology_NN ,_, the_DT intensity_NN of_IN in_IN vivo_NN ERα_NNP expression_NN
          can_MD be_VB utilized_JJ for_IN discrimination_NN between_IN the_DT two_CD basic_JJ
          categories_NNS only_RB ,_, the_DT normal_JJ (_( NP_NNP ;_: PT_NNP 1_CD and_CC PT_NNP 2_LS )_) and_CC the_DT
          abnormal_JJ placentae_NN (_( AP_NNP ;_: PT_NNP 3_CD and_CC PT_NNP 4_LS )_) ._. Observations_NNP
          supporting_VBG this_DT view_NN follow_VB ._. Possible_JJ exceptions_NNS for_IN PT_NNP 1_CD
          are_VBP indicated_VBN in_IN Table_NNP 1_CD and_CC in_IN discussion_NN ._.
        
        
          Placental_NNP immunohistochemistry_NN (_( Figure_NN 3_LS )_)
          Figures_NNS 3_CD Aand_NNP 3_CD Bshow_NNP that_DT h-_NN 151_CD and_CC ID_NNP 5_CD anti-_NN ERα_NNP
          antibodies_NNS exhibit_NN similar_JJ nuclear_JJ staining_VBG of_IN MCF-_NNP 7_CD
          cells_NNS ;_: no_DT staining_VBG in_IN the_DT MCF-_NNP 7_CD culture_NN is_VBZ apparent_JJ with_IN
          control_NN antibody_NN recognizing_VBG CD_NNP 3_CD of_IN T_NN cells_NNS (_( Fig_NNP ._. 3_LS C_NNP )_) ._.
          The_DT immunoreactivity_NN of_IN ID_NNP 5_CD antibody_NN is_VBZ shown_VBN in_IN Fig_NNP ._. 3_LS D_NNP ,_,
          3_CD E_NNP ,_, and_CC G-N_NNP ._. In_IN normal_JJ placentae_NN ,_, the_DT ERα_NNP was_VBD strongly_RB
          expressed_VBN in_IN cytotrophoblast_NN nuclei_NN (_( c_SYM ,_, Fig_NNP ._. 3_LS D_NNP )_) lying_VBG
          beneath_IN trophoblastic_JJ syncytium_NN (_( S_NNP )_) ,_, which_WDT showed_VBD no_DT
          staining_VBG of_IN the_DT nuclei_NN ._. Fig_NNP ._. 3_LS Eshows_NNP that_IN cytotrophoblast_NN
          cells_NNS merging_VBG with_IN the_DT syncytium_NN exhibit_NN a_DT diminution_NN of_IN
          ERα_NNP expression_NN (_( compare_VB with_IN 3_CD D_NNP )_) ._. Such_JJ occasionally_RB
          observed_VBD differentiation_NN of_IN cytotrophoblast_NN cells_NNS was_VBD
          associated_VBN with_IN weak_JJ cytoplasmic_JJ staining_VBG of_IN the_DT
          syncytium_NN ._. Yet_RB the_DT syncytial_NN nuclei_NN never_RB exerted_VBN ERα_NNP
          immunoreactivity_NN (_( S_NNP ,_, Fig_NNP ._. 4_LS E_NNP )_) ._. Control_NNP staining_VBG with_IN CD_NNP 3_CD
          antibody_NN (_( Fig_NNP ._. 3_LS F_NN )_) shows_VBZ an_DT isolated_VBN T_NN cell_NN in_IN the_DT
          villous_JJ core_NN ,_, but_CC no_DT staining_VBG of_IN other_JJ villous_JJ
          structures_NNS ._. Substitution_NNP of_IN primary_JJ antibody_NN with_IN PBS_NNP
          produced_VBD no_DT staining_VBG (_( not_RB shown_VBN )_) ._.
          In_IN addition_NN to_TO cytotrophoblast_NN cells_NNS ,_, ERα_NNP
          immunoreactivity_NN was_VBD also_RB detected_VBN in_IN villous_JJ vessels_NNS and_CC
          sinusoids_NNS (_( v_NN )_) ._. However_RB ,_, this_DT staining_VBG was_VBD not_RB associated_VBN
          with_IN the_DT nuclei_NN of_IN endothelial_NN cells_NNS (_( black_JJ arrows_NNS ,_, Fig_NNP ._.
          3_LS Gand_NNP 3_CD H_NNP )_) ,_, but_CC with_IN adjacent_JJ pericytes_NNS (_( PC_NN and_CC white_JJ
          arrow_NN ,_, Fig_NNP ._. 3_LS H_NNP )_) ,_, i_NNP ._. e_SYM ._. cells_NNS originating_VBG from_IN placental_NN
          fibroblasts_NNS ._.
          However_RB ,_, cytotrophoblast_NN cells_NNS with_IN nuclear_JJ ERα_NNP
          immunoreactivity_NN were_VBD not_RB detected_VBN in_IN every_DT placenta_NN
          investigated_VBN ._. Fig_NNP ._. 3_LS Ishows_NNP an_DT abnormal_JJ placenta_NN with_IN a_DT
          lack_NN of_IN ERα_NNP staining_VBG except_IN in_IN the_DT villous_JJ vessels_NNS ._. Fig_NNP ._.
          3_LS Jdemonstrates_NNP the_DT ERα_NNP staining_VBG of_IN small_JJ (_( resting_VBG )_)
          fibroblasts_NNS ,_, persisting_VBG after_IN vascular_NN regression_NN in_IN some_DT
          villi_NN in_IN the_DT placenta_NN shown_VBN in_IN Fig_NNP ._. 3_LS I_PRP ._.
          All_DT placentae_NN showed_VBD ERα_NNP staining_VBG of_IN resting_VBG
          fibroblasts_NNS beneath_IN the_DT amniotic_JJ epithelium_NN (_( Fig_NNP ._. 3_LS K_NNP )_) ,_,
          but_CC amniotic_JJ epithelium_NN itself_PRP showed_VBD no_DT immunoreactivity_NN
          (_( Fig_NNP ._. 3_LS L_NNP )_) ._. Unexpectedly_NNP ,_, no_DT ERα_NNP immunoreactivity_NN was_VBD
          found_VBN in_IN extravillous_JJ trophoblast_NN cells_NNS and_CC adjacent_JJ
          decidual_NN cells_NNS ,_, either_CC in_IN chorion_NN laeve_NN (_( Fig_NNP ._. 3_LS Mand_NNP 3_CD N_NNP )_)
          or_CC at_IN the_DT placental_NN basal_NN plate_NN (_( not_RB shown_VBN )_) ._. Fig_NNP ._. 3_LS Oshows_NNP
          staining_VBG for_IN Thy-_NNP 1_CD differentiation_NN protein_NN ,_, which_WDT allows_VBZ
          discrimination_NN between_IN unstained_JJ extravillous_JJ trophoblast_NN
          cells_NNS (_( left_VBD )_) and_CC Thy-_NNP 1_CD +_NN decidual_NN cells_NNS (_( right_NN )_) ._. Note_VB a_DT
          lack_NN of_IN Thy-_NNP 1_CD +_NN fibroblasts_NNS among_IN extravillous_JJ trophoblast_NN
          cells_NNS ._.
        
        
          Trophoblast_NNP cultures_NNS (_( Figure_NN 4_LS )_)
          Figure_NN 4_CD shows_VBZ ERα_NNP immunoreactivity_NN in_IN early_JJ (_( 17_CD h_NN )_) and_CC
          late_JJ (_( 93_CD h_NN )_) trophoblast_NN cultures_NNS derived_VBN from_IN normal_JJ
          placenta_NN ._. In_IN early_JJ cultures_NNS ,_, the_DT dividing_VBG trophoblast_NN
          cells_NNS exhibited_VBN surface_NN ERα_NNP expression_NN (_( arrow_NN ,_, Fig_NNP ._. 4_LS A_DT )_) ._.
          Non-dividing_NNP trophoblast_NN cells_NNS showed_VBD
          cytoplasmic_JJ /_NN perinuclear_NN (_( arrowhead_NN ,_, Fig_NNP ._. 4_LS B_NNP )_) or_CC
          perinuclear_NN /_NN nuclear_JJ ERα_NNP immunoreactivity_NN (_( Fig_NNP ._. 4_LS C_NNP )_) ._. The_DT
          latter_NN was_VBD accompanied_VBN by_IN diminution_NN of_IN cell_NN surface_NN
          staining_VBG ._. Fig_NNP ._. 4_LS Dshows_NNP syncytium_NN formation_NN in_IN the_DT early_JJ
          culture_NN ,_, with_IN traces_NNS of_IN cytoplasmic_JJ (_( white_JJ arrowheads_NNS ,_,
          compare_VB with_IN panel_NN 4_CD E_NNP )_) but_CC no_DT nuclear_JJ ERα_NNP
          immunoreactivity_NN ._. Mature_NNP syncytia_NN in_IN late_JJ cultures_NNS showed_VBD
          no_DT cytoplasmic_JJ or_CC nuclear_JJ ERα_NNP immunoreactivity_NN (_( Fig_NNP ._. 4_LS E_NNP )_) ._.
          Some_DT late_JJ cultures_NNS derived_VBN from_IN PT_NNP 2_CD types_NNS showed_VBD a_DT
          mixture_NN of_IN well_RB developed_VBN syncytia_NN and_CC persisting_VBG
          mononucleated_JJ trophoblast_NN cells_NNS with_IN ERα_NNP
          immunoreactivity_NN ._. However_RB ,_, in_IN late_JJ cultures_NNS from_IN abnormal_JJ
          placentae_NN ,_, the_DT formation_NN of_IN syncytia_NN was_VBD abortive_JJ (_( see_VB
          below_IN )_) and_CC such_JJ small_JJ syncytia_NN showed_VBD regressive_JJ changes_NNS
          and_CC persisting_VBG cytoplasmic_JJ ERα_NNP immunoreactivity_NN (_( not_RB
          shown_VBN )_) ._.
        
        
          Variability_NNP of_IN outcome_NN in_IN trophoblast_NN cultures_NNS
          (_( Figure_NN 5_LS )_)
          Figures_NNS 5_CD shows_VBZ that_IN trophoblast_NN cultures_NNS from_IN normal_JJ
          placentae_NN ,_, characterized_VBN by_IN strong_JJ Thy-_NNP 1_CD expression_NN in_IN
          the_DT villous_JJ core_NN (_( panel_NN A_DT )_) ,_, exhibit_NN progressive_JJ formation_NN
          of_IN mid-sized_JJ (_( m_NN )_) and_CC large_JJ syncytial_NN aggregates_NNS (_( l_NN )_) in_IN
          early_JJ (_( EC_NNP ,_, panel_NN B_NNP )_) and_CC late_JJ cultures_NNS (_( LC_NNP ,_, panel_NN C_NNP )_) ._. In_IN
          contrast_NN ,_, trophoblast_NN cultures_NNS from_IN abnormal_JJ placentae_NN ,_,
          which_WDT are_VBP characterized_VBN by_IN weak_JJ or_CC no_DT Thy-_NNP 1_CD expression_NN in_IN
          the_DT villous_JJ core_NN (_( panel_NN D_NNP )_) ,_, exhibit_NN abortive_JJ formation_NN of_IN
          small_JJ (_( s_VBZ )_) syncytial_NN aggregates_NNS (_( panels_NNS E_NNP and_CC F_NN )_) ._.
          The_DT ERα_NNP expression_NN in_IN normal_JJ placentae_NN is_VBZ high_JJ (_( top_NN of_IN
          inset_NN A_DT )_) ,_, and_CC transformation_NN of_IN cytotrophoblast_NN cells_NNS
          into_IN the_DT large_JJ syncytia_NN (_( ~_NN 300_CD μm_NN in_IN diameter_NN )_) is_VBZ
          accompanied_VBN by_IN ERα_NNP diminution_NN (_( top_JJ insets_NNS B_NNP and_CC C_NNP ;_: see_VB
          also_RB Fig_NNP ._. 4_LS E_NNP )_) ._. On_IN the_DT other_JJ hand_NN ,_, abnormal_JJ placentae_NN show_NN
          almost_RB no_DT ERα_NNP expression_NN in_IN vivo_NN (_( top_JJ inset_NN Fig_NNP ._. 5_LS D_NNP )_) ._.
          However_RB ,_, strong_JJ ERα_NNP expression_NN is_VBZ apparent_JJ in_IN early_JJ
          culture_NN (_( top_JJ inset_NN E_NNP )_) ,_, and_CC persists_VBZ thereafter_RB (_( top_JJ inset_NN
          F_NN )_) ,_, apparently_RB due_JJ to_TO the_DT lack_NN of_IN mature_VBP syncytium_NN
          formation_NN ._. Bottom_NNP insets_NNS show_VBP actin_NN expression_NN ._.
          Quantitative_NNP evaluation_NN and_CC statistical_JJ analysis_NN of_IN
          ERα_NNP expression_NN in_IN the_DT placentae_NN and_CC trophoblast_NN cultures_NNS
          are_VBP shown_VBN in_IN Fig_NNP ._. 5_LS G_NNP (_( error_NN bars_NNS indicate_VBP SD_NNP )_) ._.
          Nonparametric_NNP ANOVA_NNP was_VBD extremely_RB significant_JJ (_( 
          P_NN <_NN 0_CD ._. 0001_CD )_) ._. Dunn_NNP 's_POS Multiple_NNP
          Comparisons_NNP Test_NNP indicated_VBD a_DT significant_JJ difference_NN in_IN
          ERα_NNP expression_NN between_IN normal_JJ placenta_NN (_( PT_NNP 1_CD in_IN vivo_NN )_) vs_NNS ._.
          corresponding_JJ late_JJ culture_NN (_( PT_NNP 1_CD LC_NNP )_) ,_, 
          P_NN <_NN 0_CD ._. 01_CD ._. Normal_NNP placenta_NN (_( PT_NNP 1_CD
          in_IN vivo_NN )_) showed_VBD significantly_RB higher_JJR ERα_NNP expression_NN when_WRB
          compared_VBN to_TO PT_NNP 4_CD in_IN vivo_NN (_( 
          P_NN <_NN 0_CD ._. 001_CD )_) ._. Trophoblast_NNP cultures_NNS
          from_IN PT_NNP 4_CD showed_VBD a_DT high_JJ increase_NN when_WRB compared_VBN to_TO the_DT PT_NNP 4_CD
          in_IN vivo_NN (_( P_NN <_NN 0_CD ._. 01_CD )_) but_CC there_EX was_VBD no_DT significant_JJ
          difference_NN when_WRB the_DT PT_NNP 4_CD early_JJ and_CC late_JJ cultures_NNS were_VBD
          compared_VBN ._. However_RB ,_, late_JJ PT_NNP 1_CD culture_NN (_( PT_NNP 1_CD LC_NNP )_) showed_VBD
          significantly_RB lower_JJR ERα_NNP vs_NNS ._. both_DT PT_NNP 4_CD cultures_NNS (_( P_NN <_NN
          0_CD ._. 05_CD )_) ._. This_DT correlated_JJ with_IN differences_NNS in_IN syncytium_NN
          formation_NN (_( Fig_NNP ._. 5_LS Cvs_NNP ._. 5_LS F_NN )_) ._.
        
        
          Variability_NNP of_IN placental_NN ERα_NNP expression_NN (_( Figure_NN
          6_CD )_)
          In_IN western_JJ blot_NN analysis_NN of_IN the_DT ten_CD placental_NN samples_NNS
          investigated_VBN ,_, five_CD showed_VBD a_DT distinct_JJ ERα_NNP band_NN at_IN ~_NN 65_CD kDa_NN
          and_CC five_CD exhibited_VBN barely_RB detectable_JJ ERα_NNP expression_NN (_( Fig_NNP ._.
          6_CD A_DT )_) ._. Note_VB that_IN in_IN Fig_NNP ._. 6_CD A_DT ,_, the_DT placentae_NN with_IN strong_JJ ERα_NNP
          expression_NN belong_VB to_TO the_DT PT_NNP 1_CD (_( normal_JJ )_) or_CC PT_NNP 2_CD (_( slightly_RB
          abnormal_JJ )_) types_NNS ,_, while_IN placentae_NN with_IN low_JJ ERα_NNP expression_NN
          belong_VB to_TO the_DT PT_NNP 3_CD and_CC PT_NNP 4_CD types_NNS (_( moderate_JJ and_CC severe_JJ
          abnormality_NN )_) ._. For_IN statistical_JJ purposes_NNS in_IN this_DT study_NN ,_, the_DT
          PT_NNP 1_CD (_( normal_JJ )_) and_CC PT_NNP 2_CD placentae_NN (_( slightly_RB abnormal_JJ with_IN
          compensatory_JJ villous_JJ differentiation_NN )_) were_VBD coupled_VBN as_IN
          normal_JJ placentae_NN (_( NP_NNP )_) ._. The_DT PT_NNP 3_CD (_( moderate_JJ abnormality_NN
          compensated_VBN by_IN maximum_NN dilatation_NN of_IN sinusoids_NNS )_) and_CC PT_NNP 4_CD
          placentae_NN (_( severe_JJ abnormality_NN without_IN compensatory_JJ
          vascular_NN dilatation_NN )_) were_VBD coupled_VBN as_IN abnormal_JJ placentae_NN
          (_( AP_NNP )_) ._.
          Figures_NNS 6_CD Band_NNP 6_CD Cdemonstrate_NNP ERα_NNP expression_NN in_IN early_JJ
          and_CC late_JJ trophoblast_NN cultures_NNS ._. Interestingly_RB ,_, the_DT PT_NNP 2_CD in_IN
          lane_NN 2_CD shows_VBZ a_DT diminution_NN of_IN ERα_NNP expression_NN already_RB at_IN
          early_JJ culture_NN ,_, possibly_RB due_JJ to_TO the_DT accelerated_VBN syncytium_NN
          formation_NN already_RB activated_VBN 
          in_IN vivo_NN [_NN 30_CD ]_NN ._.
          Fig_NNP ._. 6_CD Dsummarizes_NNP the_DT data_NNS on_IN ERα_NNP expression_NN in_IN all_DT
          ten_CD placentae_NN and_CC cultures_NNS presented_VBN in_IN panels_NNS 6_CD A-C_NNP ._. It_PRP
          is_VBZ apparent_JJ that_IN high_JJ ERα_NNP expression_NN in_IN normal_JJ placentae_NN
          in_IN vivo_NN was_VBD relatively_RB constant_JJ ,_, yet_RB there_EX were_VBD marked_VBN
          differences_NNS among_IN trophoblast_NN cultures_NNS ,_, ranging_VBG from_IN ERα_NNP
          diminution_NN to_TO persisting_VBG ERα_NNP expression_NN ._. Indeed_RB ,_, only_RB a_DT
          small_JJ proportion_NN of_IN trophoblast_NN cultures_NNS from_IN PT_NNP 2_CD
          placentae_NN showed_VBD complete_JJ transformation_NN of_IN
          cytotrophoblast_NN cells_NNS into_IN the_DT syncytia_NN ,_, while_IN in_IN others_NNS
          mature_VBP syncytia_NN were_VBD accompanied_VBN by_IN cytotrophoblast_NN
          cells_NNS ._.
          Nonparametric_NNP ANOVA_NNP for_IN Fig_NNP 6_CD Dwas_NNP extremely_RB
          significant_JJ (_( 
          P_NN <_NN 0_CD ._. 0001_CD )_) ._. Dunn_NNP 's_POS Multiple_NNP
          Comparisons_NNP Test_NNP indicated_VBD significant_JJ difference_NN in_IN ERα_NNP
          expression_NN between_IN NP_NNP in_IN vivo_NN when_WRB compared_VBN to_TO AP_NNP in_IN vivo_NN
          (_( 
          P_NN <_NN 0_CD ._. 01_CD )_) ._. Estrogen_NNP receptor_NN
          alpha_NN expression_NN in_IN AP_NNP in_IN vivo_NN was_VBD also_RB significantly_RB
          lower_JJR compared_VBN to_TO all_DT other_JJ columns_NNS at_IN 
          P_NN <_NN 0_CD ._. 001_CD ._. Interestingly_RB ,_, the_DT
          ERα_NNP expression_NN in_IN AP_NNP early_JJ and_CC late_JJ cultures_NNS
          significantly_RB exceeded_VBD that_IN of_IN NP_NNP in_IN vivo_NN (_( 
          P_NN <_NN 0_CD ._. 001_CD )_) ._.
          Altogether_RB ,_, very_RB low_JJ in_IN vivo_NN ERα_NNP expression_NN in_IN all_DT
          moderately_RB and_CC severely_RB abnormal_JJ placentae_NN rose_VBD
          significantly_RB (_( several_JJ fold_VB )_) in_IN early_JJ cultures_NNS ,_, and_CC high_JJ
          expression_NN remained_VBD unchanged_JJ in_IN late_JJ cultures_NNS ._. This_DT
          correlated_JJ with_IN poor_JJ development_NN of_IN syncytial_NN
          aggregates_NNS ._.
        
        
          The_DT role_NN of_IN E_NNP 2_CD in_IN terminal_NN differentiation_NN of_IN
          trophoblast_NN cells_NNS (_( Figures_NNS 7_CD and_CC 8_CD )_)
          Trophoblast_NNP cultures_NNS from_IN six_CD additional_JJ term_NN
          placentae_NN were_VBD studied_VBN for_IN trophoblast_NN differentiation_NN in_IN
          normal_JJ DMEM-HG_NNP medium_NN with_IN phenol_NN red_JJ (_( PhR_NNP +_NN )_) ,_, in_IN phenol_NN
          red-free_JJ medium_NN without_IN E_NNP 2_CD (_( PhR-_NNP /_NN E_NNP 2_CD -_: )_) ,_, and_CC in_IN phenol_NN
          red-free_JJ medium_NN with_IN 20_CD nM_NN E_NNP 2_CD (_( PhR-_NNP /_NN E_NNP 2_CD +_NN )_) ._. Three_CD placentae_NN
          were_VBD classified_VBN as_IN normal_JJ (_( two_CD PT_NNP 1_CD and_CC one_CD PT_NNP 2_LS )_) ,_, and_CC
          three_CD as_IN abnormal_JJ (_( two_CD PT_NNP 3_CD and_CC one_CD PT_NNP 4_LS )_) ._. All_DT time_NN 0_CD
          (_( freshly_RB isolated_VBN )_) trophoblast_NN cells_NNS and_CC early_JJ cultures_NNS
          showed_VBD distinct_JJ ERα_NNP bands_NNS ,_, regardless_RB of_IN the_DT absence_NN
          (_( E_NNP 2_CD -_: )_) or_CC presence_NN of_IN E_NNP 2_CD or_CC PhR_NNP in_IN the_DT media_NNS during_IN
          trophoblast_NN separation_NN ,_, and_CC regardless_RB of_IN their_PRP$ origin_NN
          from_IN normal_JJ or_CC abnormal_JJ placentae_NN ._. Late_RB cultures_NNS showed_VBD
          lower_JJR ERα_NNP expression_NN in_IN cell_NN lysates_NNS from_IN normal_JJ
          placentae_NN when_WRB compared_VBN to_TO that_DT from_IN abnormal_JJ placentae_NN
          (_( data_NNS not_RB shown_VBN )_) ._.
          Trophoblast_NNP cells_NNS from_IN normal_JJ placentae_NN cultured_JJ in_IN
          PhR_NNP +_NN medium_NN formed_VBD mid-sized_JJ syncytial_NN clusters_NNS in_IN early_JJ
          cultures_NNS and_CC large_JJ syncytial_NN clusters_NNS in_IN late_JJ cultures_NNS
          (_( l_NN ,_, Fig_NNP ._. 7_CD A_DT ,_, see_VB also_RB Fig_NNP ._. 5_LS Band_NNP 5_CD C_NNP )_) ._. The_DT same_JJ cells_NNS
          cultured_JJ in_IN PhR-_NNP /_NN E_NNP 2_CD -_: medium_NN showed_VBD a_DT retardation_NN of_IN
          syncytium_NN formation_NN in_IN early_JJ and_CC late_JJ cultures_NNS ,_, where_WRB
          they_PRP did_VBD not_RB exceed_VB clusters_NNS of_IN small_JJ size_NN (_( s_VBZ ,_, Fig_NNP ._. 7_CD B_NNP )_) ._.
          Trophoblast_NNP cells_NNS divided_VBN (_( short_JJ arrows_NNS )_) and_CC associated_VBN
          together_RB ,_, yet_RB often_RB without_IN fusing_NN (_( long_JJ arrow_NN ,_, Fig_NNP 7_CD B_NNP )_) ._.
          However_RB ,_, PhR-_NNP /_NN E_NNP 2_CD +_NN medium_NN caused_VBN marked_VBD acceleration_NN of_IN
          trophoblast_NN differentiation_NN in_IN early_JJ cultures_NNS ,_, where_WRB the_DT
          syncytial_NN clusters_NNS already_RB reached_VBD a_DT large_JJ size_NN ._. In_IN
          addition_NN ,_, late_JJ cultures_NNS showed_VBD formation_NN of_IN extremely_RB
          large_JJ syncytial_NN aggregates_NNS (_( xl_NN ,_, Fig_NNP ._. 7_CD C_NNP )_) ._.
          Trophoblast_NNP cells_NNS from_IN abnormal_JJ placentae_NN (_( AP_NNP )_)
          cultured_JJ in_IN PhR_NNP +_NN medium_NN formed_VBD small_JJ syncytial_NN clusters_NNS
          in_IN early_JJ cultures_NNS and_CC rare_JJ mid-sized_JJ clusters_NNS in_IN late_JJ
          cultures_NNS (_( m_NN ,_, Fig_NNP ._. 7_CD D_NNP ,_, see_VB also_RB Fig_NNP ._. 5_LS Eand_NNP 5_CD F_NN )_) ._. The_DT same_JJ
          cells_NNS cultured_JJ in_IN PhR-_NNP /_NN E_NNP 2_CD -_: medium_NN showed_VBD severe_JJ
          retardation_NN of_IN syncytium_NN formation_NN in_IN early_JJ and_CC late_JJ
          cultures_NNS (_( Fig_NNP ._. 7_CD E_NNP )_) ._. However_RB ,_, PhR-_NNP /_NN E_NNP 2_CD +_NN medium_NN stimulated_VBN
          trophoblast_NN differentiation_NN in_IN early_JJ and_CC late_JJ cultures_NNS ,_,
          where_WRB syncytial_NN aggregates_NNS reached_VBD a_DT large_JJ size_NN (_( Fig_NNP ._.
          7_CD F_NN )_) ._.
          Fig_NNP ._. 8_CD summarizes_NNS the_DT data_NNS on_IN the_DT extent_NN of_IN syncytium_NN
          formation_NN in_IN late_JJ trophoblast_NN cultures_NNS from_IN three_CD NP_NNP and_CC
          three_CD AP_NNP studied_VBD ._. It_PRP is_VBZ apparent_JJ that_IN PhR_NNP +_NN media_NNS
          stimulated_VBN syncytium_NN formation_NN in_IN NP_NNP but_CC not_RB AP_NNP ._. Lack_NN of_IN
          estrogens_NNS (_( PhR-_NNP /_NN E_NNP 2_CD -_: )_) caused_VBN retardation_NN and_CC E_NNP 2_CD
          supplementation_NN stimulated_VBN syncytium_NN formation_NN in_IN
          trophoblast_NN cultures_NNS derived_VBN from_IN both_DT normal_JJ and_CC
          abnormal_JJ placentae_NN ._.
          Nonparametric_NNP ANOVA_NNP for_IN Fig_NNP 8_CD was_VBD extremely_RB significant_JJ
          (_( 
          P_NN <_NN 0_CD ._. 0001_CD )_) ._. Dunn_NNP 's_POS Multiple_NNP
          Comparisons_NNP Test_NNP indicated_VBD significant_JJ differences_NNS in_IN ERα_NNP
          expression_NN at_IN 
          P_NN <_NN 0_CD ._. 01_CD as_IN indicated_VBN by_IN
          different_JJ column_NN superscripts_NNS in_IN Fig_NNP ._. 8_CD ._. Note_VB that_IN the_DT
          measurement_NN of_IN extra_JJ large_JJ syncytium_NN aggregates_NNS in_IN NP_NNP
          PhR-_NNP /_NN E_NNP 2_CD +_NN (_( see_VB xl_NN ,_, Fig_NNP ._. 7_CD C_NNP )_) was_VBD limited_VBN by_IN a_DT maximum_NN view_NN
          area_NN representing_VBG 90000_CD sq_NN μm_NN (_( see_VB Materials_NNPS and_CC
          Methods_NNP )_) ._.
          Altogether_RB ,_, E_NNP 2_CD appears_VBZ to_TO stimulate_VB terminal_NN
          differentiation_NN of_IN trophoblast_NN cells_NNS derived_VBN from_IN normal_JJ
          and_CC abnormal_JJ placentae_NN (_( both_DT expressing_VBG ERα_NNP in_IN vitro_NN )_) and_CC
          to_TO enhance_VB a_DT fusion_NN of_IN syncytial_NN clusters_NNS into_IN extremely_RB
          large_JJ aggregates_NNS ._. The_DT presence_NN of_IN phenol_NN red_JJ ,_, a_DT weak_JJ
          estrogen_NN ,_, in_IN the_DT culture_NN is_VBZ sufficient_JJ to_TO stimulate_VB
          differentiation_NN of_IN trophoblast_NN cells_NNS into_IN large_JJ syncytia_NN
          in_IN cultures_NNS from_IN normal_JJ placentae_NN ,_, but_CC not_RB from_IN abnormal_JJ
          ones_NNS ._.
        
      
      
        Discussion_NNP
        This_DT is_VBZ the_DT first_JJ demonstration_NN of_IN ERα_NNP protein_NN
        expression_NN in_IN human_JJ placentae_NN by_IN western_JJ blot_NN analysis_NN ._.
        Nuclear_NNP ERα_NNP expression_NN was_VBD confined_VBN to_TO the_DT villous_JJ
        mononucleated_JJ trophoblast_NN cells_NNS associated_VBN with_IN
        trophoblastic_JJ syncytium_NN and_CC differentiating_VBG cultured_JJ
        cytotrophoblast_NN cells_NNS ._. No_DT nuclear_JJ ERα_NNP staining_VBG was_VBD detected_VBN
        in_IN trophoblastic_JJ syncytia_NN in_IN vivo_NN or_CC in_IN vitro_NN ._.
        Unexpectedly_NNP ,_, extravillous_JJ trophoblast_NN cells_NNS also_RB lacked_VBD
        ERα_NNP ._. These_DT observations_NNS indicate_VBP that_IN trophoblastic_JJ nuclear_JJ
        ERα_NNP expression_NN is_VBZ characteristic_NN of_IN cytotrophoblast_NN cells_NNS
        differentiating_VBG into_IN syncytial_NN structures_NNS ,_, but_CC not_RB for_IN
        resting_VBG cytotrophoblast_NN cells_NNS ._. Additional_JJ placental_NN cell_NN
        types_NNS expressing_VBG the_DT ERα_NNP were_VBD fibroblast-derived_JJ vascular_NN
        pericytes_NNS and_CC extravillous_JJ (_( amniotic_JJ )_) fibroblasts_NNS ._.
        Estrogens_NNP may_MD ,_, via_IN the_DT ERα_NNP ,_, contribute_VB to_TO the_DT stimulation_NN
        of_IN terminal_NN differentiation_NN of_IN mononucleated_JJ trophoblast_NN
        cells_NNS into_IN syncytial_NN aggregates_NNS ._. Terminal_NNP trophoblast_NN
        differentiation_NN is_VBZ associated_VBN with_IN diminution_NN of_IN ERα_NNP
        expression_NN ._.
        Nuclear_NNP ERα_NNP expression_NN is_VBZ characteristic_NN of_IN
        estrogen-sensitive_JJ cells_NNS ,_, which_WDT might_MD be_VB stimulated_VBN by_IN
        estrogens_NNS to_TO proliferate_VBP as_RB well_RB as_IN modulate_VBP differentiated_JJ
        functions_NNS ._. In_IN placental_NN material_NN ERα_NNP expression_NN determined_VBN
        by_IN western_JJ blot_NN analysis_NN showed_VBD either_CC strong_JJ ERα_NNP or_CC barely_RB
        detectable_JJ ERα_NNP bands_NNS ,_, and_CC where_WRB investigated_VBN ,_, there_EX were_VBD no_DT
        transitions_NNS between_IN these_DT two_CD types_NNS of_IN ERα_NNP expression_NN ._. In_IN
        addition_NN ,_, strong_JJ ERα_NNP expression_NN was_VBD associated_VBN with_IN normal_JJ
        placentae_NN (_( PT_NNP 1_CD and_CC PT_NNP 2_LS )_) ,_, suggesting_VBG that_IN in_IN these_DT term_NN
        pregnancies_NNS ERα_NNP +_NN cytotrophoblast_NN cells_NNS contribute_VBP to_TO
        syncytium_NN differentiation_NN ._. On_IN the_DT other_JJ hand_NN ,_, placentae_NN
        exhibiting_VBG moderate_JJ and_CC severe_JJ abnormality_NN showed_VBD virtually_RB
        no_DT ERα_NNP expression_NN by_IN western_JJ blot_NN analysis_NN or_CC
        immunohistochemical_JJ staining_VBG of_IN tissue_NN sections_NNS (_( except_IN the_DT
        vessels_NNS )_) ._. This_DT indicates_VBZ there_EX is_VBZ no_DT syncytium_NN
        differentiation_NN ,_, although_IN the_DT senescent_NN placentae_NN of_IN
        females_NNS of_IN advanced_JJ maternal_NN age_NN were_VBD reported_VBN to_TO exhibit_VB a_DT
        higher_JJR number_NN of_IN Ki-_NNP 67_CD (_( dividing_VBG )_) mononuclear_NN trophoblast_NN
        cells_NNS [_NN 29_CD ]_NN ._. These_DT observations_NNS suggest_VBP that_IN dividing_VBG
        cytotrophoblast_NN cells_NNS do_VBP not_RB necessarily_RB contribute_VB to_TO
        syncytium_NN differentiation_NN and_CC may_MD not_RB express_VB ERα_NNP ._.
        An_DT unexpected_JJ feature_NN was_VBD the_DT strong_JJ ERα_NNP expression_NN of_IN
        cultured_JJ trophoblast_NN cells_NNS derived_VBN from_IN placentae_NN deficient_NN
        in_IN ERα_NNP expression_NN in_IN vivo_NN ._. This_DT observation_NN indicates_VBZ that_IN
        the_DT lack_NN of_IN ERα_NNP expression_NN in_IN vivo_NN is_VBZ not_RB due_JJ to_TO the_DT
        inability_NN of_IN trophoblast_NN cells_NNS to_TO express_VB ERα_NNP in_IN general_NN ._.
        It_PRP might_MD be_VB speculated_VBN that_IN under_IN conditions_NNS of_IN tissue_NN
        culture_NN factors_NNS modulating_VBG ERα_NNP expression_NN are_VBP different_JJ
        from_IN that_DT in_IN vivo_NN ._. Given_VBN that_IN ERα_NNP expression_NN is_VBZ already_RB
        enhanced_VBN at_IN the_DT end_NN of_IN the_DT cell_NN separation_NN (_( time_NN 0_CD )_) ,_, ERα_NNP
        expression_NN appears_VBZ to_TO be_VB inhibited_VBD in_IN vivo_NN ._.
        Virtual_NNP lack_NN of_IN in_IN vivo_NN ERα_NNP expression_NN seems_VBZ to_TO be_VB an_DT
        additional_JJ indicator_NN of_IN moderate_JJ and_CC severe_JJ placental_NN
        abnormality_NN ._. Based_VBN on_IN in_IN vivo_NN ERα_NNP expression_NN ,_, the_DT placentae_NN
        may_MD be_VB divided_VBN into_IN the_DT two_CD basic_JJ categories_NNS ,_, normal_JJ
        placentae_NN :_: NP_NNP ,_, ERα_NNP +_NN ,_, and_CC abnormal_JJ placentae_NN :_: AP_NNP ,_, ERα-_NNP ._.
        However_RB ,_, it_PRP should_MD be_VB considered_VBN that_IN some_DT PT_NNP 1_CD placentae_NN ,_,
        the_DT functions_NNS of_IN which_WDT are_VBP in_IN harmony_NN with_IN actual_JJ fetal_JJ
        demands_NNS ,_, may_MD not_RB exhibit_VB compensatory_JJ differentiation_NN of_IN
        trophoblast_NN cells_NNS and_CC ,_, therefore_RB ,_, may_MD not_RB express_VB ERα_NNP in_IN
        vivo_NN (_( Table_NNP 1_LS )_) ._. The_DT existence_NN of_IN placental_NN aging_NN is_VBZ still_RB
        debated_VBN ,_, yet_RB various_JJ clinical_JJ ,_, morphological_JJ ,_, cellular_JJ and_CC
        molecular_JJ aspects_NNS of_IN placental_NN senescence_NN have_VBP been_VBN
        indicated_VBN [_NN 20_CD 21_CD 24_CD 25_CD 27_CD 28_CD 29_CD 30_CD 45_CD 46_CD 47_CD ]_NN ._. However_RB ,_,
        it_PRP is_VBZ still_RB unclear_JJ if_IN there_EX are_VBP any_DT consequences_NNS of_IN
        placental_NN aging_VBG for_IN normal_JJ pregnancy_NN ,_, delivery_NN ,_, and_CC
        neonatal_NN birth_NN weight_NN and_CC Apgar_NNP scores_NNS [_NN 29_CD 48_CD 49_CD ]_NN ._. It_PRP
        has_VBZ to_TO be_VB noted_VBN that_IN even_RB the_DT abnormal_JJ placenta_NN may_MD have_VB
        the_DT capacity_NN to_TO improve_VB its_PRP$ function_NN and_CC compensate_VB for_IN
        demands_NNS of_IN the_DT growing_VBG fetus_NN ,_, e_SYM ._. g_SYM ._. ,_, by_IN elongation_NN and_CC
        excessive_JJ dilatation_NN of_IN villous_JJ sinusoids_NNS [_NN 26_CD 50_CD ]_NN ._.
        As_IN recently_RB indicated_VBD [_NN 30_CD ]_NN ,_, certain_JJ types_NNS of_IN
        placental_NN abnormality_NN have_VBP also_RB been_VBN ascribed_VBN to_TO the_DT
        villous_JJ immaturity_NN (_( low_JJ or_CC no_DT Thy-_NNP 1_CD differentiation_NN protein_NN
        expression_NN in_IN placental_NN villi_NN and_CC a_DT lack_NN of_IN blood_NN sinusoid_NN
        dilatation_NN -_: PT_NNP 4_CD ,_, see_VBP above_IN )_) accompanied_VBN by_IN an_DT existing_VBG
        (_( diabetes_NN mellitus_JJ )_) or_CC absent_JJ placental_NN hypertrophy_NN
        (_( intrauterine_JJ growth_NN retardation_NN )_) -_: Table_NNP 1_CD ._. However_RB ,_, it_PRP
        has_VBZ been_VBN suggested_VBN that_IN although_IN chronic_JJ placental_NN
        adaptations_NNS may_MD be_VB successful_JJ for_IN the_DT fetal_JJ survival_NN ,_, e_SYM ._. g_SYM ._.
        in_IN placental_NN senescence_NN or_CC maternal_NN diabetes_NN ,_, they_PRP may_MD lead_VB
        to_TO adverse_JJ outcomes_NNS later_RB in_IN the_DT life_NN of_IN an_DT individual_JJ [_NN 22_CD
        ]_NN ._. Therefore_RB ,_, although_IN it_PRP might_MD not_RB be_VB apparent_JJ in_IN the_DT
        newborn_JJ ,_, the_DT abnormal_JJ placenta_NN may_MD indicate_VB a_DT burden_NN for_IN
        the_DT future_NN of_IN an_DT individual_JJ and_CC for_IN the_DT quality_NN of_IN the_DT
        human_JJ population_NN ._. Yet_RB ,_, placental_NN abnormality_NN is_VBZ not_RB a_DT rare_JJ
        event_NN ,_, since_IN it_PRP has_VBZ been_VBN found_VBN in_IN 50_CD %_NN of_IN the_DT cases_NNS in_IN our_PRP$
        material_NN ._.
        The_DT second_JJ cell_NN type_NN expressing_VBG the_DT ERα_NNP were_VBD amniotic_JJ
        fibroblasts_NNS and_CC fibroblast-derived_JJ vascular_NN pericytes_NNS ._.
        Estrogen_NNP receptors_NNS have_VBP been_VBN identified_VBN in_IN cultured_JJ
        fibroblasts_NNS of_IN various_JJ origins_NNS and_CC vascular_NN smooth_JJ muscle_NN
        cells_NNS [_NN 51_CD 52_CD 53_CD ]_NN ._. Estrogens_NNP enhance_VB proliferation_NN of_IN
        fibroblasts_NNS and_CC inhibit_VB vascular_NN smooth_JJ muscle_NN migration_NN [_NN
        54_CD 55_CD ]_NN ._. Binding_NNP of_IN estrogens_NNS to_TO fibroblasts_NNS also_RB
        stimulates_NNS fibroblast_NN interaction_NN with_IN epithelial_NN cells_NNS
        with_IN subsequent_JJ acceleration_NN of_IN maturation_NN of_IN epithelial_NN
        cells_NNS [_NN 56_CD ]_NN ._.
        The_DT last_JJ observation_NN is_VBZ of_IN particular_JJ importance_NN to_TO
        several_JJ aspects_NNS of_IN this_DT study_NN ._. Activated_NNP Thy-_NNP 1_CD +_NN villous_JJ
        fibroblasts_NNS ,_, characterized_VBN by_IN secretion_NN of_IN Thy-_NNP 1_CD
        differentiation_NN protein_NN among_IN epithelial_NN cells_NNS in_IN vivo_NN and_CC
        among_IN cultured_JJ trophoblast_NN cells_NNS in_IN vitro_NN [_NN 57_CD 58_CD ]_NN ,_, are_VBP
        present_JJ in_IN PT_NNP 1_CD and_CC PT_NNP 2_CD ,_, but_CC absent_JJ from_IN PT_NNP 3_CD and_CC PT_NNP 4_CD
        placentae_NN [_NN 30_CD ]_NN (_( see_VB also_RB Fig_NNP ._. 5_LS Avs_NNP ._. 5_LS D_NNP )_) ._. Various_JJ types_NNS of_IN
        placental_NN mesenchymal_NN cells_NNS inevitably_RB accompany_VB "_'' purified_JJ "_''
        trophoblast_NN cells_NNS [_NN 41_CD ]_NN ,_, and_CC highly_RB activated_VBN Thy-_NNP 1_CD +_NN
        fibroblasts_NNS are_VBP present_JJ in_IN early_JJ trophoblast_NN cultures_NNS [_NN 58_CD
        ]_NN ._. Extravillous_NNP trophoblast_NN cells_NNS do_VBP not_RB express_VB ERα_NNP ,_, yet_RB
        indeed_RB ,_, there_EX are_VBP no_DT Thy-_NNP 1_CD +_NN fibroblasts_NNS among_IN the_DT basal_NN
        plate_NN and_CC chorion_NN laeve_NN extravillous_JJ trophoblast_NN cells_NNS (_( see_VB
        Fig_NNP ._. 3_LS O_NNP )_) ._. Hence_RB ,_, Thy-_NNP 1_CD +_NN fibroblasts_NNS may_MD stimulate_VB
        differentiation_NN and_CC ERα_NNP expression_NN in_IN mononucleated_JJ
        trophoblast_NN cells_NNS ._.
        Although_IN estrogens_NNS were_VBD suspected_VBN to_TO stimulate_VB
        trophoblast_NN differentiation_NN [_NN 12_CD 59_CD ]_NN ,_, no_DT direct_JJ proof_NN has_VBZ
        been_VBN provided_VBN up_RP to_TO date_NN ._. Trophoblast_NNP cells_NNS derived_VBN from_IN
        normal_JJ placentae_NN differentiated_JJ into_IN large_JJ syncytial_NN
        clusters_NNS in_IN the_DT presence_NN of_IN PhR_NNP without_IN E_NNP 2_CD supplementation_NN ._.
        Phenol_NNP red_JJ in_IN tissue_NN culture_NN media_NNS is_VBZ a_DT weak_JJ estrogen_NN ,_,
        sufficient_JJ to_TO stimulate_VB the_DT proliferation_NN of_IN ERα_NNP +_NN MCF-_NNP 7_CD
        human_JJ breast_NN carcinoma_NN cells_NNS [_NN 36_CD ]_NN ._. We_PRP report_VBP a_DT similar_JJ
        estrogenic_JJ effect_NN of_IN PhR_NNP +_NN media_NNS on_IN trophoblast_NN
        differentiation_NN and_CC syncytium_NN formation_NN in_IN cultures_NNS from_IN
        normal_JJ placentae_NN ,_, but_CC not_RB from_IN abnormal_JJ ones_NNS ._.
        Because_IN trophoblast_NN cultures_NNS derived_VBN from_IN both_DT the_DT
        normal_JJ and_CC abnormal_JJ placentae_NN were_VBD ERα_NNP +_NN in_IN time_NN 0_CD cell_NN
        lysates_NNS ,_, the_DT above_JJ difference_NN can_MD not_RB be_VB ascribed_VBN to_TO the_DT
        lack_NN of_IN ERα_NNP expression_NN ._. Yet_RB ,_, ERα_NNP at_IN mid-pregnancy_JJ levels_NNS
        further_RBR stimulated_VBN syncytium_NN development_NN ,_, as_IN evidenced_VBN by_IN
        the_DT development_NN of_IN extremely_RB large_JJ syncytial_NN aggregates_NNS in_IN
        late_JJ cultures_NNS from_IN normal_JJ placentae_NN ,_, and_CC development_NN of_IN
        large_JJ syncytial_NN aggregates_NNS in_IN cultures_NNS from_IN abnormal_JJ
        placentae_NN ._. Hence_RB ,_, trophoblast_NN cells_NNS from_IN abnormal_JJ placentae_NN
        are_VBP also_RB capable_JJ of_IN differentiating_VBG in_IN response_NN to_TO
        estrogenic_JJ stimuli_NNS ,_, but_CC the_DT level_NN of_IN estrogens_NNS must_MD be_VB
        higher_JJR ._. However_RB ,_, it_PRP is_VBZ important_JJ to_TO note_VB that_IN
        pharmacological_JJ levels_NNS of_IN E_NNP 2_CD (_( 200_CD nM_NN )_) have_VBP been_VBN found_VBN to_TO
        suppress_VB development_NN of_IN syncytial_NN aggregates_NNS even_RB in_IN
        cultures_NNS derived_VBN from_IN normal_JJ placentae_NN (_( unpublished_JJ data_NNS )_) ._.
        Hence_RB ,_, either_CC low_JJ or_CC extremely_RB high_JJ levels_NNS of_IN estrogens_NNS in_IN
        vivo_NN may_MD cause_VB a_DT suppression_NN of_IN placental_NN syncytium_NN
        formation_NN ._.
        Our_PRP$ observations_NNS indicate_VBP that_IN the_DT cultures_NNS from_IN normal_JJ
        and_CC abnormal_JJ placentae_NN contain_VB similar_JJ trophoblast_NN cells_NNS
        capable_JJ of_IN differentiating_VBG in_IN response_NN to_TO exogenous_JJ
        estrogens_NNS ,_, but_CC they_PRP may_MD differ_VB in_IN the_DT ability_NN of_IN
        accompanying_VBG mesenchymal_NN cells_NNS to_TO promote_VB this_DT process_NN ._. One_PRP
        might_MD speculate_VB that_IN in_IN cultures_NNS derived_VBN from_IN normal_JJ
        placentae_NN ,_, the_DT weak_JJ estrogenic_JJ effect_NN of_IN PhR_NNP is_VBZ sufficient_JJ
        to_TO stimulate_VB trophoblast_NN /_NN mesenchymal_NN cell_NN interactions_NNS in_IN
        vitro_NN resulting_VBG in_IN a_DT local_JJ production_NN of_IN estrogens_NNS ._. It_PRP is_VBZ
        possible_JJ that_IN the_DT estrogens_NNS can_MD be_VB secreted_JJ by_IN the_DT
        syncytiotrophoblast_NN clusters_NNS and_CC fibroblasts_NNS ,_, because_IN these_DT
        cell_NN types_NNS express_VBP the_DT enzyme_NN aromatase_NN [_NN 60_CD ]_NN ._. Indeed_RB ,_,
        trophoblast_NN cultures_NNS are_VBP capable_JJ of_IN producing_VBG estrogens_NNS [_NN
        35_CD ]_NN ._.
        The_DT data_NNS are_VBP summarized_VBD in_IN Table_NNP 2_CD ._. Our_PRP$ observations_NNS
        rise_VBP a_DT fundamental_JJ question_NN if_IN E_NNP 2_CD is_VBZ not_RB ,_, in_IN fact_NN ,_, an_DT
        essential_JJ input_NN for_IN trophoblast_NN differentiation_NN ._. Yet_RB ,_,
        previous_JJ experience_NN has_VBZ shown_VBN that_IN lower_JJR estrogen_NN levels_NNS
        during_IN pregnancy_NN are_VBP indicative_JJ of_IN poor_JJ fetal_JJ condition_NN [_NN 5_CD
        ]_NN ._.
      
      
        Conclusion_NNP
        Placental_NNP ERα_NNP expression_NN in_IN vivo_NN is_VBZ high_JJ in_IN normal_JJ
        placentae_NN and_CC barely_RB detectable_JJ in_IN abnormal_JJ placentae_NN ._. The_DT
        significant_JJ increase_NN of_IN estrogen_NN production_NN occurring_VBG with_IN
        pregnancy_NN advancement_NN may_MD play_VB a_DT role_NN ,_, via_IN the_DT ERα_NNP ,_, in_IN the_DT
        stimulation_NN of_IN terminal_NN differentiation_NN of_IN mononucleated_JJ
        trophoblast_NN cells_NNS into_IN syncytial_NN aggregates_NNS and_CC promote_VB
        placental_NN function_NN ._. This_DT mechanism_NN ,_, however_RB ,_, may_MD not_RB
        operate_VB in_IN abnormal_JJ placentae_NN ,_, which_WDT show_VBP a_DT lack_NN of_IN ERα_NNP
        expression_NN ._.
      
    
  
